≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Type 1 diabetes, wide definition, subgroup 2

DOID EFO Endpoint Browser

T1D_WIDE2

type I diabetes mellitus: A chronic condition characterized by minimal or absent production of insulin by the pancreas.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

  • not PANCREATITIS
  • and not INSULIN_INTER_AND_LONG
  • and KELA_DIAB_INSUL
  • and INSULIN_SHORTFAST
1162

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

679

6. Filter based on genotype QC (FinnGen only)

656

Control definitions (FinnGen only)

Control exclude
DIABETES_FG
Control conditions
not PANCREATITIS
and not INSULIN_INTER_AND_LONG
and not KELA_DIAB_INSUL
and not INSULIN_SHORTFAST

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8193 3476 4409
Only index persons 2249 991 1258
Unadjusted period prevalence (%)
Whole population 0.12 0.10 0.12
Only index persons 0.04 0.04 0.05
Median age at first event (years)
Whole population 53.87 58.28 50.15
Only index persons 48.96 53.50 45.38

-FinnGen-

Key figures

All Female Male
Number of individuals 656 287 369
Unadjusted period prevalence (%) 0.14 0.10 0.17
Median age at first event (years) 56.58 57.46 55.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
679
Matched controls
6790
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A10AB01
ATC
insulin (human); parenteral
16384.0
307.7
528
*
A10AC01
ATC
insulin (human); parenteral
4495.3
307.7
613
14
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
+∞
307.7
320
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
288.3
307.7
397
33
A10AA01, ,
ATC
+∞
307.7
343
*
103
Kela drug reimbursment
Diabetes, insulin-treated
+∞
307.7
679
*
A10BA02
ATC
metformin; oral
93.2
307.7
253
43
A10AA02, ,
ATC
+∞
307.7
476
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
+∞
307.4
271
*
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
+∞
282.7
251
*
A10AB05
ATC
insulin aspart; parenteral
572.2
269.7
251
7
A10AD01
ATC
insulin (human); parenteral
+∞
259.5
232
*
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3174.8
256.0
231
*
A10BB01
ATC
glibenclamide; oral
814.5
239.6
222
*
A10AB04
ATC
insulin lispro; parenteral
2920.4
213.2
195
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
96.4
189.4
99
12
215
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
182.8
167
*
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
+∞
179.3
164
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
+∞
164.4
151
*
A10BX01
ATC
guar gum; oral
24.3
156.3
116
57
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
+∞
129.4
120
*
H04AA01
ATC
glucagon; nasal, parenteral
+∞
120.5
112
*
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
+∞
118.3
110
*
A10AD05
ATC
insulin aspart; parenteral
+∞
114.9
107
*
A10AA03, ,
ATC
+∞
111.6
104
*
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1114.2
100.8
96
*
A98
ICPC
Health maint/preventive medicine
0.2
99.3
168
4495
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
17.2
94.6
81
53
CKC10
NOMESCO Finland
Local photocoagulation of retina
21.0
90.4
70
37
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
5.8
86.7
198
450
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
+∞
86.3
81
*
T89
ICPC
Diabetes insulin dependent
242.4
84.5
85
*
NHQ40
NOMESCO Finland
Amputation of toe
19.5
83.7
67
38
4019X
ICD-9 Finland
Essential hypertension, Unspecified
8.7
81.7
113
152
T90
ICPC
Diabetes non-insulin dependent
11.1
80.1
90
92
C02EA02, ,
ATC
7.7
79.8
125
194
C09AA02
ATC
enalapril; systemic
4.6
79.8
284
923
A12AA04
ATC
calcium carbonate; oral
21.1
78.1
60
31
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
14.8
77.8
72
54
XCK10
NOMESCO Finland
Photography of fundus of eye
7.4
77.8
127
206
A10AE04
ATC
insulin glargine; parenteral
416.9
76.4
75
*
A10BB12
ATC
glimepiride; oral
170.8
73.6
76
5
201
Kela drug reimbursment
Chronic cardiac insufficiency
5.9
69.8
146
302
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
739.9
69.3
67
*
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
715.4
67.2
65
*
C09AA01
ATC
captopril; oral
11.4
65.2
71
69
H36.00
ICD-10 Finland
Diabetic background retinopathy
+∞
64.6
61
*
H3601, E113,
ICD-10 Finland
+∞
63.5
60
*
A11CC03
ATC
alfacalcidol; systemic
12.3
62.2
64
57
205
Kela drug reimbursment
Chronic hypertension
3.7
61.6
341
1458
H3603, E113,
ICD-10 Finland
+∞
59.2
56
*
2507A
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI II]
+∞
59.2
56
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
606.9
57.5
56
*
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
+∞
57.1
54
*
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
+∞
56.0
53
*
E10
ICD-10 Finland
Type 1 diabetes mellitus
+∞
53.9
51
*
A10AE05
ATC
insulin detemir; parenteral
199.1
53.8
55
*
H36.01
ICD-10 Finland
Diabetic maculopathy
+∞
52.8
50
*
H3600, E113,
ICD-10 Finland
+∞
52.8
50
*
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
548.0
52.2
51
*
B03XA01
ATC
erythropoietin; parenteral
15.3
51.5
46
32
C03CA01
ATC
furosemide; systemic
3.2
47.2
406
2166
N02BE01
ATC
paracetamol; systemic, rectal
0.3
47.2
268
4582
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
+∞
46.4
44
*
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
+∞
46.4
44
*
4148X
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]
12.2
46.0
47
41
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
478.4
45.8
45
*
A10BB07
ATC
glipizide; oral
164.2
44.4
46
*
I50.1
ICD-10 Finland
Left ventricular failure
5.2
44.3
100
218
H43.1
ICD-10 Finland
Vitreous haemorrhage
11.7
43.7
46
42
2505A
ICD-9 Finland
Diabetes mellitus, Diabetes with ophthalmic manifestations[NEUROPATHIA DIABETICA,TYYPPI II]
+∞
43.2
41
*
81
HP
Angiography of the heart and coronary arteries
4.6
43.1
116
292
C10AB02
ATC
bezafibrate; oral
14.7
42.8
39
28
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
+∞
42.1
40
*
2500X
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,NUD]
+∞
42.1
40
*
H3600, E103,
ICD-10 Finland
+∞
40.0
38
*
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
+∞
40.0
38
*
CKC15
NOMESCO Finland
Panretinal photocoagulation
54.7
39.1
46
9
NGQ20
NOMESCO Finland
Amputation of lower leg
54.7
39.1
46
9
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
+∞
38.9
37
*
4402A
ICD-9 Finland
Atherosclerosis, Of native arteries of the extremities
8.8
38.5
50
61
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
+∞
37.9
36
*
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
387.6
37.4
37
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
6.9
36.8
59
92
H3603, E103,
ICD-10 Finland
+∞
36.8
35
*
B01AC06
ATC
acetylsalicylic acid; oral
4.6
36.5
96
236
E11
ICD-10 Finland
Type 2 diabetes mellitus
9.5
36.3
44
49
C01DA14
ATC
isosorbide mononitrate; oral
2.8
34.9
249
1154
TK800
NOMESCO Finland
Hemodialysis
11.5
34.9
37
34
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.7
34.4
304
1570
NFQ20
NOMESCO Finland
Amputation of femur
13.9
34.2
32
24
A12BA01
ATC
potassium chloride; oral
3.9
33.6
110
318
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
+∞
33.6
32
*
J01DA01
ATC
[U] cefalexin
2.8
33.0
471
3052
V03AE01
ATC
polystyrene sulfonate; oral
10.5
33.0
37
37
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
+∞
32.6
31
*
J01FF01
ATC
clindamycin; systemic
2.8
31.6
204
891
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
+∞
31.5
30
*
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.7
31.1
247
1198
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
167.6
30.9
32
*
WX110
NOMESCO Finland
Infiltration anesthesia
0.3
30.9
125
2818
C01AA05
ATC
digoxin; systemic
3.0
30.3
166
661
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
71.4
30.2
34
5
B01AC07
ATC
dipyridamole; systemic
3.5
29.9
116
375
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
52.6
29.6
35
7
C02EA01, ,
ATC
9.9
29.1
34
36
40199
ICD-8 Finland
Essential benign hypertension
5.9
28.9
54
98
SAA01
NOMESCO Finland
Simple examination of mouth
0.3
28.8
115
2644
4120X
ICD-9 Finland
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]
6.3
28.6
50
85
M01AH05
ATC
etoricoxib; oral
0.3
28.6
76
2176
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
+∞
28.3
27
*
I50.0
ICD-10 Finland
Congestive heart failure
3.1
28.0
134
492
11
HP
Coronary artery bypass surgery
6.0
27.8
51
91
C02DE04, ,
ATC
4.6
27.6
69
162
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.5
27.2
262
1375
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
64.8
27.2
31
5
137
Kela drug reimbursment
Uraemia requiring dialysis
26.0
26.8
37
15
C08DB01
ATC
diltiazem; oral
3.5
26.5
100
317
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
+∞
26.2
25
*
25008
ICD-8 Finland
Diabetes mellitus, Complicatio alia definita
+∞
26.2
25
*
4130B
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]
6.0
25.9
47
83
40299
ICD-8 Finland
Hypertensive heart disease
10.4
25.8
29
29
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.8
25.8
165
709
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
52.2
25.4
30
6
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
+∞
25.2
24
*
SAA02
NOMESCO Finland
Basic examination of mouth
0.3
25.1
98
2332
P20
ICPC
Memory disturbance
0.1
25.1
8
822
4130X
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]
5.2
24.8
53
109
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
+∞
24.1
23
*
N083, E112,
ICD-10 Finland
+∞
24.1
23
*
I25.2
ICD-10 Finland
Old myocardial infarction
3.1
24.1
115
420
SPAT1053
SPAT
Memory test
0.1
23.8
8
791
5315
FHL
Bypass surgery using a mammary artery
6.9
23.6
37
56
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
20.3
22.3
33
17
D01AC02
ATC
miconazole; topical
3.4
22.2
89
292
B05DA
ATC
Isotonic solutions
30.2
22.0
29
10
2504A
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYP II]
+∞
22.0
21
*
B05DB
ATC
Hypertonic solutions
44.9
21.5
26
6
4289X
ICD-9 Finland
Heart failure, unspecified
8.7
21.1
27
32
A10AD04
ATC
insulin lispro; parenteral
+∞
20.9
20
*
2506A
ICD-9 Finland
Diabetes mellitus, Diabetes with neurological manifestations[MICROANGIOPATHIA DIABETICA,TYYPPI II]
+∞
20.9
20
*
A10BH01
ATC
sitagliptin; oral
216.4
20.7
21
*
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
5.2
20.7
44
90
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
8.5
20.6
27
33
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
19.0
20.6
31
17
K85
ICPC
Elevated blood pressure
0.1
20.5
6
662
J01DA09
ATC
[U] cefadroxil
2.3
20.1
189
961
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
3.1
20.1
91
321
J01MA01
ATC
ofloxacin; systemic
2.9
20.0
102
385
H3601, E103,
ICD-10 Finland
+∞
19.9
19
*
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
+∞
19.9
19
*
A10AC30
ATC
insulins and analogues for injection, intermediate-acting - combinations; parenteral
+∞
19.9
19
*
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
3.2
19.9
88
306
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
4.0
19.4
58
156
G04AA01, ,
ATC
6.9
19.3
30
45
42700
ICD-8 Finland
Symptomatic heart disease, Congestive heart failure
18.9
19.2
29
16
Z49.1
ICD-10 Finland
Extracorporeal dialysis
15.4
19.1
31
21
I21.9
ICD-10 Finland
Acute myocardial infarction, unspecified
4.1
19.0
55
144
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
+∞
18.8
18
*
N083, E102,
ICD-10 Finland
+∞
18.8
18
*
4100X
ICD-9 Finland
Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]
4.2
18.8
52
132
S18
ICPC
Laceration/cut
0.3
18.7
75
1830
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
195.2
18.6
19
*
SFA20
NOMESCO Finland
Two-surface restoration
0.3
18.6
80
1888
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
5.6
18.2
35
65
N18.8
ICD-10 Finland
Other chronic renal failure
5.2
18.0
38
77
SPAT1262
SPAT
Handing over of treatment supplies
2.9
17.9
93
354
SFA10
NOMESCO Finland
One-surface restoration
0.4
17.9
81
1872
3620B
ICD-9 Finland
Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]
+∞
17.8
17
*
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
184.6
17.6
18
*
XCK20, ,
NOMESCO Finland
+∞
16.7
16
*
2503B
ICD-9 Finland
Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]
+∞
16.7
16
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
+∞
16.7
16
*
J01DB01
ATC
cefalexin; oral
0.5
16.7
281
3965
C09BA02
ATC
enalapril and diuretics; systemic
3.1
16.6
75
263
N06AA09
ATC
amitriptyline; systemic
3.0
16.5
80
292
C07AG02
ATC
carvedilol; oral
3.3
16.5
65
210
E87.5
ICD-10 Finland
Hyperkalaemia
6.5
16.4
27
43
D03BA52
ATC
collagenase, combinations; topical
12.1
16.2
29
25
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
0.4
16.1
81
1804
AA1AD
NOMESCO Finland
CT of head and brain
0.3
16.1
52
1433
GD1AA
NOMESCO Finland
Thorax X-ray examination
0.4
16.0
111
2158
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.3
15.8
63
1565
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
+∞
15.7
15
*
25009
ICD-8 Finland
Diabetes mellitus, Unspecified
+∞
15.7
15
*
2506B
ICD-9 Finland
Diabetes mellitus, Diabetes with neurological manifestations[MICROANGIOPATHIA DIABETICA,TYYPPI I]
+∞
15.7
15
*
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
+∞
15.7
15
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.2
15.7
27
1070
M04AA01
ATC
allopurinol; systemic
2.3
15.6
131
628
J01CF02
ATC
cloxacillin; systemic
5.6
15.5
30
56
N17
ICPC
Vertigo/dizziness
0.1
15.5
6
542
SPAT1263
SPAT
Sampling
0.4
15.5
72
1670
K86
ICPC
Hypertension uncomplicated
0.1
15.5
*
467
4120B
ICD-9 Finland
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]
5.2
15.4
32
64
OAB50, ,
SPAT
4.7
15.3
36
80
C09AA03
ATC
lisinopril; oral
3.7
15.3
50
143
27799
ICD-8 Finland
Obesity not specified as of endocrine origin
29.4
15.3
20
7
C03DA01
ATC
spironolactone; oral
2.4
15.1
112
507
M79.6
ICD-10 Finland
Pain in limb
0.4
15.1
70
1628
B03XA02
ATC
darbepoetin alfa; parenteral
5.6
15.1
29
54
5314
FHL
Bypass surgery for four or more vessels
5.7
14.9
28
51
N18.0
ICD-10 Finland
End-stage renal disease
11.7
14.9
27
24
C07AB08
ATC
celiprolol; oral
4.3
14.8
39
95
J01DA06
ATC
[U] cefuroxime
2.5
14.8
104
460
H28.0*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic cataract
+∞
14.6
14
*
2505B
ICD-9 Finland
Diabetes mellitus, Diabetes with ophthalmic manifestations[NEUROPATHIA DIABETICA,TYYPPI I]
+∞
14.6
14
*
I79.2*E10.5
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
+∞
14.6
14
*
B06AA55
ATC
streptokinase, combinations; systemic, topical
36.9
14.5
18
5
SPAT1153
SPAT
Removal of sutures
0.3
14.5
36
1154
N02AJ06
ATC
codeine and paracetamol; systemic
0.3
14.5
52
1371
K02.1
ICD-10 Finland
Caries of dentine
0.4
14.3
101
1974
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.5
14.2
95
409
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.3
14.2
45
1267
A28
ICPC
Limited function/disability NOS
0.3
14.0
31
1065
G04AC01, ,
ATC
3.6
14.0
48
142
SPAT1325
SPAT
Vaccination
0.4
13.9
65
1518
C08CA02
ATC
felodipine; oral
2.5
13.9
97
427
Z49.2
ICD-10 Finland
Other dialysis
24.4
13.8
19
8
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
4.3
13.8
36
87
SPAT1301
SPAT
No procedures
0.3
13.7
48
1288
KMAK, ,
NOMESCO Finland
0.4
13.7
79
1684
G04AB05, ,
ATC
4.2
13.7
37
92
J01MA02
ATC
ciprofloxacin; systemic
1.9
13.6
279
1845
H360, E113,
ICD-10 Finland
+∞
13.6
13
*
2503A
ICD-9 Finland
Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI II]
+∞
13.6
13
*
E11.01
ICD-10 Finland
Non-insulin dependent diabetes diabetic coma with hyperglycaemia
+∞
13.6
13
*
E10.0
ICD-10 Finland
Type 1 diabetes mellitus, With coma
+∞
13.6
13
*
E14.8
ICD-10 Finland
Unspecified diabetes mellitus, with unspecified complications
+∞
13.6
13
*
25004
ICD-8 Finland
Diabetes mellitus, Nephropathia diabetica. Polyneuritis diabetica
+∞
13.6
13
*
3626
FHL
Extracapsular cataract surgery and implantation of an artificial lens
3.7
13.6
44
125
C07AB02
ATC
metoprolol; systemic
1.9
13.0
198
1184
M25.5
ICD-10 Finland
Pain in joint
0.3
12.8
32
1030
Z01.2
ICD-10 Finland
Dental examination
0.4
12.8
67
1494
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
3.7
12.7
41
116
A02BC02
ATC
pantoprazole; systemic
0.5
12.7
218
3187
280
Kela drug reimbursment
Clopidogrel
4.6
12.7
30
67
I20.00
ICD-10 Finland
Unstable angina
3.6
12.7
43
126
315
Kela drug reimbursment
Clopidogrel
6.1
12.7
22
37
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.4
12.6
71
1539
SPAT1216
SPAT
Assessment of functional ability
0.2
12.6
14
751
N08.3
ICD-10 Finland
Glomerular disorders in diabetes mellitus
+∞
12.5
12
*
M14.6*E11.6
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic neuropathic
+∞
12.5
12
*
2507X
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICATIONE ALIA ,NUD]
+∞
12.5
12
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.8
12.5
67
258
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
0.4
12.5
83
1681
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.2
12.4
13
727
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
3.9
12.3
36
95
L03
ICPC
Low back symptom/complaint
0.2
12.3
24
894
J01XX05
ATC
methenamine; oral
4.7
12.2
28
61
J01XE01
ATC
nitrofurantoin; oral
4.3
12.2
32
78
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
4.3
12.1
31
74
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
27.3
12.1
16
6
C10AB04
ATC
gemfibrozil; oral
10.3
12.1
23
23
C02DE02, ,
ATC
4.1
12.1
33
83
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.6
12.0
75
312
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
4.2
12.0
32
79
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.3
12.0
37
1066
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
0.3
12.0
35
1038
M54.5
ICD-10 Finland
Low back pain
0.4
11.9
54
1292
N03AF01
ATC
carbamazepine; oral, rectal
3.1
11.9
52
179
0093A
ICD-9 Finland
Ill-defined intestinal infections, Diarrhoea of presumed infectious origin
10.8
11.8
22
21
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
3.2
11.8
48
158
S82
ICPC
Naevus/mole
0.1
11.8
*
400
SDA03
NOMESCO Finland
Periodontal treatment
0.3
11.7
43
1135
H13
ICPC
Plugged feeling ear
0.2
11.7
21
823
C03BA08
ATC
metolazone; oral
66.1
11.6
13
*
B04AC02, ,
ATC
19.3
11.6
17
9
A10BK01
ATC
dapagliflozin; oral
23.4
11.6
16
7
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
23.4
11.6
16
7
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.5
11.6
76
324
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.3
11.6
25
879
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
0.3
11.5
43
1129
25005
ICD-8 Finland
Diabetes mellitus, Neuropathia diabetica. Polyneuritis diabetica
+∞
11.5
11
*
N02AC04
ATC
dextropropoxyphene; oral
2.9
11.5
57
211
61
HP
Catheterization and pressure measurement of the left side of the heart
4.3
11.4
29
69
Z49.0
ICD-10 Finland
Preparatory care for dialysis
15.4
11.4
18
12
H29
ICPC
Ear symptom/complaint other
0.1
11.3
6
435
C02AC05
ATC
moxonidine; oral
3.7
11.3
36
101
A12AA12
ATC
[U] calcium acetate
35.7
11.3
14
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
35.7
11.3
14
*
Z71.8
ICD-10 Finland
Other specified counselling
0.3
11.3
44
1131
C02CA01
ATC
prazosin; oral
4.1
11.1
31
79
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
4.1
11.0
30
75
H81
ICPC
Excessive ear wax
0.2
11.0
21
798
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
3.1
10.9
47
160
D03BA02
ATC
collagenase; topical
15.8
10.9
17
11
L28
ICPC
Limited function/disability (L)
0.3
10.9
32
950
104
Kela drug reimbursment
Thyroid insufficiency
2.8
10.9
58
223
SPAT1310
SPAT
Counselling related to known health issue
0.3
10.9
40
1060
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
18.2
10.8
16
9
B04AB02, ,
ATC
3.6
10.7
35
100
Z94.0
ICD-10 Finland
Kidney transplant status
13.2
10.7
18
14
WW200, ,
SPAT
0.3
10.7
29
900
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.8
10.7
230
1519
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
3.3
10.6
41
131
127
Kela drug reimbursment
Transplant complication
9.4
10.6
21
23
5253
FHL
Cardiac lung machine
4.9
10.5
23
48
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.2
10.5
18
732
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
0.1
10.5
*
370
SPAT1312
SPAT
General health counselling
0.4
10.5
43
1086
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.2
10.5
13
653
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
10.5
177
1085
I20.01
ICD-10 Finland
Unstable angina
3.7
10.5
33
92
G63.2
ICD-10 Finland
Diabetic polyneuropathy
+∞
10.4
10
*
A10BD07
ATC
metformin and sitagliptin; systemic
+∞
10.4
10
*
A10BX02
ATC
repaglinide; oral
+∞
10.4
10
*
2500C
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,MODY]
+∞
10.4
10
*
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.2
10.4
15
680
I20.09
ICD-10 Finland
Unstable angina
2.6
10.2
62
254
D06AX01
ATC
fusidic acid; topical
2.4
10.2
74
330
B01AF01
ATC
rivaroxaban; oral
0.2
10.2
8
446
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
4.3
10.2
26
62
SPAT1249
SPAT
Treatment-related counselling outside office
0.4
10.1
64
1340
4029A
ICD-9 Finland
Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]
8.6
10.1
21
25
3661A
ICD-9 Finland
Cataract, Senile cataract
3.3
10.0
38
120
M01AE01
ATC
ibuprofen; systemic, rectal
0.6
9.8
332
4179
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
0.1
9.7
*
345
N06DX01
ATC
memantine; oral
0.2
9.7
15
650
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
55.8
9.7
11
*
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
2.9
9.7
47
172
M01AB05
ATC
diclofenac; systemic, rectal
0.6
9.6
194
2794
L15
ICPC
Knee symptom/complaint
0.3
9.6
21
737
WZC00
NOMESCO Finland
Treatment plan or consultation
0.4
9.6
59
1252
0088X
ICD-9 Finland
Intestinal infections due to other organisms, Other organism, not elsewhere classified
15.3
9.5
15
10
SPAT1254
SPAT
Administration of medicine
0.2
9.5
19
705
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.4
9.5
64
1311
NHS99
NOMESCO Finland
Other operation for infection of tendon, joint or bone of ankle or foot
101.4
9.4
10
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
0.4
9.4
51
1143
N02AX02
ATC
tramadol; systemic, rectal
1.7
9.4
267
1889
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.9
9.4
45
163
SAA03
NOMESCO Finland
Extended examination of mouth
0.4
9.4
58
1232
EBA00
NOMESCO Finland
Extraction of tooth
0.4
9.4
58
1232
4111X
ICD-9 Finland
Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]
4.5
9.4
23
53
B01AB05
ATC
enoxaparin; parenteral
0.4
9.4
55
1193
ZPB22
NOMESCO Finland
Autograft of vein
12.6
9.4
16
13
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
+∞
9.4
9
*
2508A
ICD-9 Finland
Diabetes mellitus, Diabetes with other specified manifestations[DIABETES MELLITUS CUM COMPLICAT NON DESCR,TYP II]
+∞
9.4
9
*
CK2S4, ,
SPAT
+∞
9.4
9
*
H3602, E113,
ICD-10 Finland
+∞
9.4
9
*
N0830, E112,
ICD-10 Finland
+∞
9.4
9
*
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
+∞
9.4
9
*
SFA30
NOMESCO Finland
Three-surface restoration
0.4
9.4
61
1268
L13
ICPC
Hip symptom/complaint
0.2
9.3
16
651
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
0.4
9.3
65
1316
SDA02
NOMESCO Finland
Periodontal treatment, brief
0.4
9.3
48
1096
N05CD07
ATC
temazepam; oral
1.9
9.2
128
734
-1, ,
NOMESCO Finland
0.4
9.2
45
1054
C03BA11
ATC
indapamide; oral
3.7
9.2
29
81
B01AF02
ATC
apixaban; oral
0.2
9.2
10
550
SPAT1304
SPAT
Counselling and guidance related to ageing
0.1
9.1
5
353
G04BX05, ,
ATC
8.5
9.1
19
23
B04AC04, ,
ATC
8.5
9.1
19
23
V03AE02
ATC
sevelamer; oral
37.2
9.0
11
*
Z51.5
ICD-10 Finland
Palliative care
0.2
9.0
9
432
41399
ICD-8 Finland
Angina pectoris, Without mention of hypertensive disease
4.0
8.9
25
64
C08CA05
ATC
nifedipine; systemic
2.3
8.8
66
299
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.3
8.8
24
747
82
HP
Single vessel balloon catheter extension
3.7
8.8
28
79
A10BK03
ATC
empagliflozin; oral
14.3
8.7
14
10
A04
ICPC
Weakness/tiredness general
0.3
8.7
23
728
R05
ICPC
Cough
0.3
8.7
31
841
K03.64
ICD-10 Finland
Dental calculus supragingival
0.4
8.6
35
895
D19
ICPC
Teeth/gum symptom/complaint
0.4
8.6
35
894
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
16.5
8.6
13
8
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.3
8.5
64
290
PFH59
NOMESCO Finland
Bypass from femoral or popliteal artery to distal anterior tibial artery
27.9
8.5
11
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
0.3
8.5
22
705
WX320
NOMESCO Finland
Spinalanesthesy
0.4
8.4
39
938
C02LM02, ,
ATC
4.7
8.4
19
41
D82
ICPC
Teeth/gum disease
0.4
8.4
50
1081
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
+∞
8.3
8
*
A10BH05
ATC
linagliptin; oral
+∞
8.3
8
*
N0830, E102,
ICD-10 Finland
+∞
8.3
8
*
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
+∞
8.3
8
*
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
+∞
8.3
8
*
6480A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
+∞
8.3
8
*
SPAT1100
SPAT
Long-term monitoring of blood pressure
0.1
8.3
*
290
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.5
8.3
114
1851
L82
ICD-10 Finland
Seborrhoeic keratosis
0.2
8.3
15
593
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
0.2
8.3
10
514
L04AA01
ATC
[U] ciclosporin
9.6
8.3
16
17
R05FB02
ATC
cough suppressants and expectorants; systemic
1.6
8.3
247
1758
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.2
8.2
16
605
C02EA03, ,
ATC
4.6
8.2
19
42
C03AA03
ATC
hydrochlorothiazide; oral
2.1
8.1
77
385
A03FA02
ATC
cisapride; oral, rectal
2.2
8.1
73
358
SDA01
NOMESCO Finland
Periodontal treatment, very brief
0.4
8.0
31
813
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
0.3
8.0
29
782
A29
ICPC
General symptom/complaint other
0.2
8.0
13
547
CKC12
NOMESCO Finland
Photocoagulation of retina
3.7
7.9
25
70
L17
ICPC
Foot/toe symptom/complaint
0.4
7.9
45
993
K78
ICPC
Atrial fibrillation/flutter
0.2
7.9
7
362
WX290
NOMESCO Finland
Other blockage of nerve
0.5
7.9
72
1331
C10AA02
ATC
lovastatin; oral
2.5
7.8
48
198
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
0.2
7.8
6
342
H02
ICPC
Hearing complaint
0.3
7.8
18
616
R74
ICPC
Upper respiratory infection acute
0.4
7.8
40
923
4140X
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,MÄÄRITTELEMÄT]
6.5
7.8
19
30
M01AC06
ATC
meloxicam; systemic, rectal
0.5
7.7
81
1434
V03AE03
ATC
lanthanum carbonate; oral
45.5
7.7
9
*
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
2.5
7.7
49
206
42792
ICD-8 Finland
Symptomatic heart disease, Fibrillatio auricularis
4.6
7.7
18
40
A11
ICPC
Chest pain NOS
0.1
7.7
*
273
N06DA02
ATC
donepezil; oral
0.2
7.6
11
502
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
7.6
19
624
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
8.2
7.6
16
20
7870A
ICD-9 Finland
Symptoms involving digestive system, Nausea and vomiting
18.6
7.6
11
6
D03AX01
ATC
cadexomer iodine; topical
18.6
7.6
11
6
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
18.6
7.6
11
6
M01AX05
ATC
glucosamine; oral
0.4
7.6
34
833
9571
FHL
Amputation of toe or toes
25.3
7.6
10
*
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
25.3
7.6
10
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.9
7.6
22
58
204
Kela drug reimbursment
Leukemia lymphatica
3.1
7.6
31
103
C07AB05
ATC
betaxolol; oral
3.3
7.5
28
88
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
0.6
7.4
108
1734
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.1
7.4
19
32
N39.4
ICD-10 Finland
Other specified urinary incontinence
0.2
7.4
6
326
A01
ICPC
Pain general/multiple sites
0.2
7.4
6
327
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.3
7.3
25
697
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
+∞
7.3
7
*
A10BJ06
ATC
semaglutide; parenteral
+∞
7.3
7
*
3620A
ICD-9 Finland
Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA NON PROLIFERATIVA]
+∞
7.3
7
*
BEF00, ,
SPAT
+∞
7.3
7
*
5901A
ICD-9 Finland
Infections of kidney, Acute pyelonephritis
6.3
7.3
18
29
I21.3
ICD-10 Finland
Acute transmural myocardial infarction of unspecified site
15.9
7.2
11
7
A97
ICPC
No disease
0.3
7.2
27
719
4140B
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]
4.0
7.2
20
51
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.3
7.2
20
619
R01AD09
ATC
mometasone; nasal
0.5
7.2
89
1500
C08CA07
ATC
nisoldipine; oral
3.5
7.2
24
70
R96
ICPC
Asthma
0.1
7.2
*
258
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.7
7.2
39
152
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.5
7.1
83
1427
C07AA07
ATC
sotalol; systemic
2.4
7.1
47
201
L57.0
ICD-10 Finland
Actinic keratosis
0.3
7.1
15
541
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
8.9
7.1
14
16
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
0.1
7.1
*
230
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
4.4
7.0
17
39
Z01.7
ICD-10 Finland
Laboratory examination
0.2
6.9
13
501
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
6.9
182
1248
M03BX02
ATC
tizanidine; oral
0.6
6.9
145
2117
C10AA01
ATC
simvastatin; oral
1.5
6.8
263
1968
N05AA02
ATC
levomepromazine; systemic
3.0
6.8
29
99
7071A
ICD-9 Finland
Chronic ulcer of skin, Ulcer of lower limbs, except decubitus
40.5
6.8
8
*
3792A
ICD-9 Finland
Other disorders of eye, Disorders of vitreous body
40.5
6.8
8
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
0.4
6.7
34
793
Z00.0
ICD-10 Finland
General medical examination
0.4
6.7
31
751
SCA01
NOMESCO Finland
Preventive oral health care, short
0.4
6.7
43
909
M70.6
ICD-10 Finland
Trochanteric bursitis
0.2
6.7
9
360
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
0.2
6.6
10
443
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.3
6.6
13
489
I22.99
ICD-10 Finland
Recurrent infarction with unspecified location unspecified coronary artery status
12.4
6.6
11
9
0092A
ICD-9 Finland
Ill-defined intestinal infections, Infectious diarrhoea
12.4
6.6
11
9
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
12.4
6.6
11
9
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
6.9
6.5
15
22
4110X
ICD-9 Finland
Other acute and subacute forms of ischaemic heart disease, Postmyocardial infarction syndrome[EPÄSTABIILI ANGINA PECTORIS,MÄÄRITTELEMÄT]
6.9
6.5
15
22
G04CB02
ATC
dutasteride; oral
0.2
6.5
8
343
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.1
6.5
*
220
S29
ICPC
Skin symptom/complaint other
0.3
6.5
23
631
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
6.3
6.5
16
26
C02DE10, ,
ATC
3.6
6.5
21
60
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
0.3
6.4
23
628
R02
ICPC
Shortness of breath/dyspnoea
0.2
6.4
11
450
Z96.4
ICD-10 Finland
Presence of endocrine implants
70.5
6.4
7
*
I20.80
ICD-10 Finland
Other angina pectoris no detected stenosis of coronary artery
4.1
6.4
17
42
S12
ICPC
Insect bite/sting
0.2
6.3
*
257
N0832, E102,
ICD-10 Finland
+∞
6.3
6
*
A10AB06
ATC
insulin glulisine; parenteral
+∞
6.3
6
*
N08.30
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
+∞
6.3
6
*
25007
ICD-8 Finland
Diabetes mellitus, Coma diabeticum
+∞
6.3
6
*
2506X
ICD-9 Finland
Diabetes mellitus, Diabetes with neurological manifestations[MICROANGIOPATHIA DIABETICA,NUD]
+∞
6.3
6
*
2508B
ICD-9 Finland
Diabetes mellitus, Diabetes with other specified manifestations[DIABETES MELLITUS CUM COMPLICAT NON DESCR,TYP I]
+∞
6.3
6
*
37700
ICD-8 Finland
Other diseases of retina and optic nerve, Haemorrhagia corporis vitrei
+∞
6.3
6
*
E11.09
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - With coma
+∞
6.3
6
*
CL2S4, ,
SPAT
+∞
6.3
6
*
A10BG02
ATC
rosiglitazone; oral
+∞
6.3
6
*
0350X
ICD-9 Finland
Erysipelas[ERYSIPELAS ALIA DEFINITA SEU NUD]
7.1
6.2
14
20
4120C
ICD-9 Finland
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,TROMBI]
26.9
6.2
8
*
QDG00
NOMESCO Finland
Debridement of bedsore of lower limb
26.9
6.2
8
*
XX3DW
NOMESCO Finland
Time consuming IT work
0.2
6.2
8
334
A44
ICPC
General and Unspecified, Preventive immunization/medic
0.2
6.2
5
274
5313
FHL
Bypass surgery for three vessels
6.4
6.2
15
24
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.5
6.2
54
1023
U04
ICPC
Incontinence urine
0.2
6.2
*
251
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
0.3
6.2
16
514
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
0.2
6.1
6
290
I20.19
ICD-10 Finland
Angina angiospastic
12.7
6.1
10
8
3643
FHL
Vitrectomy through pars Plana
12.7
6.1
10
8
A02BA03
ATC
famotidine; systemic
2.4
6.1
39
165
41099
ICD-8 Finland
Acute myocardial infarction, Without mention of hypertensive disease
3.7
6.1
19
53
G04BD12
ATC
mirabegron; oral
0.2
6.1
11
434
41300
ICD-8 Finland
Angina pectoris, Cum hypertonia
6.8
6.1
14
21
L04AA06
ATC
mycophenolic acid; systemic
6.8
6.1
14
21
WZA90
NOMESCO Finland
Other medical or dental certificate
0.4
6.1
27
665
G04BE01
ATC
alprostadil; parenteral, urethral
3.5
6.0
20
58
SPAT1260
SPAT
Consultation of another employee
0.3
6.0
21
581
J81
ICD-10 Finland
Pulmonary oedema
6.1
6.0
15
25
R53
ICD-10 Finland
Malaise and fatigue
0.5
6.0
76
1281

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
furosemide; oral, parenteral
C03CA01 [21601518]
2.1e+00
2.1e+00
1.9e+00
—
2.0e+00
2.0e+00
2.1e+00
cases:6.38%
controls:0.84%
cases:5.85%
controls:0.73%
cases:1.84%
controls:0.29%
—
—
cases:2.69%
controls:0.38%
cases:8.84%
controls:1.34%
cases:21.63%
controls:3.20%
38
49
558
5802
35
43
563
5821
11
17
587
5847
—
16
22
578
5838
52
78
536
5744
122
179
442
5420
Internal Medicine
11 [38004456]
1.2e+00
1.4e+00
1.9e+00
—
2.9e+00
2.1e+00
2.0e+00
cases:26.68%
controls:10.10%
cases:14.21%
controls:4.08%
cases:4.85%
controls:0.73%
—
—
cases:11.45%
controls:0.70%
cases:28.57%
controls:4.47%
cases:56.74%
controls:15.47%
159
591
437
5260
85
239
513
5625
29
43
569
5821
—
68
41
526
5819
168
260
420
5562
320
866
244
4733
enalapril; oral, parenteral
C09AA02 [21601786]
1.5e+00
1.5e+00
2.1e+00
—
1.8e+00
1.8e+00
1.8e+00
cases:5.37%
controls:1.20%
cases:4.85%
controls:1.07%
cases:1.84%
controls:0.22%
—
—
cases:2.02%
controls:0.34%
cases:8.16%
controls:1.41%
cases:19.50%
controls:4.00%
32
70
564
5781
29
63
569
5801
11
13
587
5851
—
12
20
582
5840
48
82
540
5740
110
224
454
5375
Case Management Agency
251B00000X [38004193]
1.1e+00
6.7e-01
1.6e+00
3.5e+00
1.8e+00
9.7e-01
6.3e-01
cases:37.42%
controls:16.34%
cases:17.22%
controls:9.62%
cases:11.54%
controls:2.68%
cases:3.34%
controls:0.10%
cases:14.14%
controls:2.71%
cases:21.60%
controls:9.50%
cases:33.16%
controls:20.93%
223
956
373
4895
103
564
495
5300
69
157
529
5707
20
6
578
5858
84
159
510
5701
127
553
461
5269
187
1172
377
4427
Outpatient Visit
OP [9202]
3.0e-01
4.9e-01
1.1e+00
5.1e+00
1.7e+00
9.0e-01
7.6e-01
cases:30.87%
controls:24.78%
cases:19.06%
controls:12.62%
cases:6.86%
controls:2.42%
cases:14.38%
controls:0.10%
cases:12.46%
controls:2.54%
cases:26.53%
controls:12.83%
cases:51.24%
controls:32.88%
184
1450
412
4401
114
740
484
5124
41
142
557
5722
86
6
512
5858
74
149
520
5711
156
747
432
5075
289
1841
275
3758
Atherosclerosis of arteries of extremities
I70.2 [45538421]
2.0e+00
2.3e+00
—
—
—
2.7e+00
2.1e+00
cases:1.68%
controls:0.22%
cases:1.34%
controls:0.14%
—
—
—
—
—
—
cases:1.53%
controls:0.10%
cases:5.32%
controls:0.68%
10
13
586
5838
8
8
590
5856
—
—
—
9
6
579
5816
30
38
534
5561
clindamycin; oral, parenteral
J01FF01 [21602985]
1.4e+00
2.3e+00
—
—
—
2.4e+00
1.8e+00
cases:2.68%
controls:0.65%
cases:1.34%
controls:0.14%
—
—
—
—
—
—
cases:2.21%
controls:0.21%
cases:7.80%
controls:1.34%
16
38
580
5813
8
8
590
5856
—
—
—
13
12
575
5810
44
75
520
5524
Inpatient Visit
IP [9201]
4.7e-01
6.5e-01
1.2e+00
—
2.5e+00
1.4e+00
1.1e+00
cases:35.74%
controls:25.77%
cases:12.88%
controls:7.15%
cases:2.68%
controls:0.78%
—
—
cases:9.93%
controls:0.87%
cases:23.13%
controls:6.87%
cases:37.23%
controls:15.88%
213
1508
383
4343
77
419
521
5445
16
46
582
5818
—
59
51
535
5809
136
400
452
5422
210
889
354
4710
Inpatient Hospital
21 [8717]
4.2e-01
9.2e-01
1.2e+00
—
2.4e+00
1.3e+00
1.1e+00
cases:12.42%
controls:8.53%
cases:10.70%
controls:4.57%
cases:3.51%
controls:1.04%
—
—
cases:6.90%
controls:0.65%
cases:18.03%
controls:5.91%
cases:48.23%
controls:23.50%
74
499
522
5352
64
268
534
5596
21
61
577
5803
—
41
38
553
5822
106
344
482
5478
272
1316
292
4283
Emergency Room Visit
ER [9203]
5.6e-01
9.3e-01
2.3e+00
1.0e+50
1.9e+00
7.8e-01
4.5e-01
cases:9.23%
controls:5.47%
cases:5.69%
controls:2.32%
cases:2.34%
controls:0.24%
cases:4.52%
controls:0.00%
cases:1.68%
controls:0.26%
cases:5.27%
controls:2.49%
cases:16.13%
controls:10.95%
55
320
541
5531
34
136
564
5728
14
14
584
5850
27
0
571
5864
10
15
584
5845
31
145
557
5677
91
613
473
4986
allopurinol; oral, parenteral
M04AA01 [21604131]
2.0e+00
2.0e+00
—
—
2.1e+00
1.7e+00
1.3e+00
cases:2.35%
controls:0.32%
cases:2.17%
controls:0.31%
—
—
—
—
cases:0.84%
controls:0.10%
cases:2.38%
controls:0.46%
cases:5.32%
controls:1.55%
14
19
582
5832
13
18
585
5846
—
—
5
6
589
5854
14
27
574
5795
30
87
534
5512
Ophthalmology
18 [38004463]
7.9e-01
1.2e+00
1.5e+00
1.0e+50
2.0e+00
1.5e+00
1.4e+00
cases:7.38%
controls:3.50%
cases:4.35%
controls:1.38%
cases:1.00%
controls:0.22%
cases:3.68%
controls:0.00%
cases:2.02%
controls:0.27%
cases:6.63%
controls:1.61%
cases:22.34%
controls:6.38%
44
205
552
5646
26
81
572
5783
6
13
592
5851
22
0
576
5864
12
16
582
5844
39
94
549
5728
126
357
438
5242
isosorbide mononitrate; oral
C01DA14 [21600324]
1.2e+00
1.0e+00
1.5e+00
—
2.1e+00
1.1e+00
1.4e+00
cases:3.36%
controls:1.01%
cases:3.34%
controls:1.21%
cases:1.17%
controls:0.27%
—
—
cases:2.53%
controls:0.32%
cases:4.93%
controls:1.67%
cases:14.72%
controls:3.98%
20
59
576
5792
20
71
578
5793
7
16
591
5848
—
15
19
579
5841
29
97
559
5725
83
223
481
5376
Pulmonary Disease
29 [38004472]
6.8e-01
1.3e+00
1.6e+00
—
2.1e+00
1.0e+00
7.6e-01
cases:4.87%
controls:2.53%
cases:4.01%
controls:1.07%
cases:1.51%
controls:0.31%
—
—
cases:1.35%
controls:0.17%
cases:3.74%
controls:1.41%
cases:9.40%
controls:4.64%
29
148
567
5703
24
63
574
5801
9
18
589
5846
—
8
10
586
5850
22
82
566
5740
53
260
511
5339
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
1.7e+00
—
—
—
—
2.5e+00
2.1e+00
cases:1.34%
controls:0.24%
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.17%
cases:2.84%
controls:0.34%
8
14
588
5837
—
—
—
—
12
10
576
5812
16
19
548
5580
glyceryl trinitrate; local oral, oral, sublingual, transdermal
C01DA02 [21600317]
9.0e-01
9.9e-01
9.0e-01
—
2.0e+00
1.0e+00
1.2e+00
cases:4.53%
controls:1.90%
cases:4.18%
controls:1.60%
cases:0.84%
controls:0.34%
—
—
cases:1.35%
controls:0.19%
cases:5.44%
controls:1.99%
cases:20.57%
controls:7.41%
27
111
569
5740
25
94
573
5770
5
20
593
5844
—
8
11
586
5849
32
116
556
5706
116
415
448
5184
felodipine; oral
C08CA02 [21601748]
1.7e+00
1.5e+00
—
—
—
1.4e+00
1.4e+00
cases:2.35%
controls:0.43%
cases:2.17%
controls:0.49%
—
—
—
—
—
—
cases:3.06%
controls:0.74%
cases:6.38%
controls:1.68%
14
25
582
5826
13
29
585
5835
—
—
—
18
43
570
5779
36
94
528
5505
Endocrinology
46 [38004485]
2.9e+00
—
—
1.0e+50
—
—
2.9e+00
cases:1.51%
controls:0.09%
—
—
—
—
cases:4.01%
controls:0.00%
—
—
—
—
cases:5.14%
controls:0.29%
9
5
587
5846
—
—
24
0
574
5864
—
—
29
16
535
5583
Outpatient Hospital
22 [8756]
6.1e-01
8.3e-01
1.0e+00
1.0e+50
2.5e+00
1.1e+00
7.8e-01
cases:10.07%
controls:5.76%
cases:5.85%
controls:2.64%
cases:1.51%
controls:0.55%
cases:3.01%
controls:0.00%
cases:3.70%
controls:0.32%
cases:9.69%
controls:3.38%
cases:29.08%
controls:15.81%
60
337
536
5514
35
155
563
5709
9
32
589
5832
18
0
580
5864
22
19
572
5841
57
197
531
5625
164
885
400
4714
digoxin; oral, parenteral
C01AA05 [21600234]
1.3e+00
1.4e+00
1.3e+00
—
1.4e+00
1.3e+00
1.8e+00
cases:2.85%
controls:0.80%
cases:4.01%
controls:1.04%
cases:0.84%
controls:0.24%
—
—
cases:1.01%
controls:0.26%
cases:4.59%
controls:1.29%
cases:16.13%
controls:3.00%
17
47
579
5804
24
61
574
5803
5
14
593
5850
—
6
15
588
5845
27
75
561
5747
91
168
473
5431
bisoprolol; oral
C07AB07 [21601689]
9.8e-01
8.4e-01
5.8e-01
—
1.7e+00
1.1e+00
1.1e+00
cases:4.53%
controls:1.74%
cases:4.01%
controls:1.77%
cases:1.34%
controls:0.75%
—
—
cases:2.19%
controls:0.39%
cases:5.95%
controls:2.10%
cases:11.70%
controls:4.32%
27
102
569
5749
24
104
574
5760
8
44
590
5820
—
13
23
581
5837
35
122
553
5700
66
242
498
5357
carvedilol; oral
C07AG02 [21601700]
2.0e+00
2.0e+00
—
—
—
1.4e+00
1.5e+00
cases:1.17%
controls:0.15%
cases:1.17%
controls:0.15%
—
—
—
—
—
—
cases:1.02%
controls:0.26%
cases:2.84%
controls:0.66%
7
9
589
5842
7
9
591
5855
—
—
—
6
15
582
5807
16
37
548
5562
Office Visit
OMOP4822458 [581477]
9.2e-01
1.8e+00
—
1.0e+50
—
1.5e+00
1.2e+00
cases:3.69%
controls:1.50%
cases:3.01%
controls:0.53%
—
—
cases:1.00%
controls:0.00%
—
—
cases:3.06%
controls:0.67%
cases:9.40%
controls:2.93%
22
88
574
5763
18
31
580
5833
—
6
0
592
5864
—
18
39
570
5783
53
164
511
5435
General Surgery
2 [38004447]
3.5e-01
3.0e-01
1.7e+00
1.0e+50
1.8e+00
8.5e-01
7.5e-01
cases:24.16%
controls:18.39%
cases:7.69%
controls:5.80%
cases:3.68%
controls:0.72%
cases:3.18%
controls:0.00%
cases:3.87%
controls:0.67%
cases:13.78%
controls:6.39%
cases:38.12%
controls:22.59%
144
1076
452
4775
46
340
552
5524
22
42
576
5822
19
0
579
5864
23
39
571
5821
81
372
507
5450
215
1265
349
4334
Pediatric Medicine
37 [38004477]
1.7e-01
1.1e-01
—
1.0e+50
2.4e+00
1.5e+00
1.5e+00
cases:1.68%
controls:1.42%
cases:0.84%
controls:0.75%
—
—
cases:3.18%
controls:0.00%
cases:2.69%
controls:0.26%
cases:2.55%
controls:0.60%
cases:3.72%
controls:0.82%
10
83
586
5768
5
44
593
5820
—
19
0
579
5864
16
15
578
5845
15
35
573
5787
21
46
543
5553
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]
5.6e-01
1.1e+00
2.8e+00
1.0e+50
—
1.5e+00
6.8e-01
cases:2.35%
controls:1.35%
cases:2.34%
controls:0.80%
cases:1.84%
controls:0.12%
cases:1.17%
controls:0.00%
—
—
cases:3.57%
controls:0.84%
cases:4.43%
controls:2.30%
14
79
582
5772
14
47
584
5817
11
7
587
5857
7
0
591
5864
—
21
49
567
5773
25
129
539
5470
diltiazem; oral
C08DB01 [21601771]
1.3e+00
1.2e+00
1.4e+00
—
—
1.3e+00
1.5e+00
cases:2.35%
controls:0.65%
cases:2.51%
controls:0.78%
cases:1.00%
controls:0.24%
—
—
—
—
cases:3.57%
controls:1.01%
cases:9.93%
controls:2.36%
14
38
582
5813
15
46
583
5818
6
14
592
5850
—
—
21
59
567
5763
56
132
508
5467
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
-5.5e-02
2.3e-01
2.4e+00
1.0e+50
2.7e+00
6.0e-01
2.6e-01
cases:2.35%
controls:2.48%
cases:2.17%
controls:1.74%
cases:2.01%
controls:0.19%
cases:2.17%
controls:0.00%
cases:3.20%
controls:0.22%
cases:2.89%
controls:1.61%
cases:4.26%
controls:3.32%
14
145
582
5706
13
102
585
5762
12
11
586
5853
13
0
585
5864
19
13
575
5847
17
94
571
5728
24
186
540
5413
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
8.9e-02
2.2e-01
2.4e+00
1.0e+50
2.6e+00
5.3e-01
2.6e-01
cases:2.68%
controls:2.46%
cases:2.17%
controls:1.76%
cases:2.01%
controls:0.19%
cases:2.17%
controls:0.00%
cases:3.03%
controls:0.22%
cases:2.72%
controls:1.61%
cases:4.26%
controls:3.32%
16
144
580
5707
13
103
585
5761
12
11
586
5853
13
0
585
5864
18
13
576
5847
16
94
572
5728
24
186
540
5413
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]
4120B [2000403592]
—
—
—
—
—
2.8e+00
2.2e+00
—
—
—
—
—
—
—
—
—
—
cases:1.70%
controls:0.10%
cases:2.48%
controls:0.29%
—
—
—
—
—
10
6
578
5816
14
16
550
5583
cefalexin; oral
J01DB01 [21602870]
6.0e-01
8.3e-01
1.5e+00
—
—
1.1e+00
9.7e-01
cases:9.90%
controls:5.71%
cases:5.69%
controls:2.56%
cases:1.84%
controls:0.41%
—
—
—
—
cases:7.31%
controls:2.66%
cases:28.37%
controls:13.04%
59
334
537
5517
34
150
564
5714
11
24
587
5840
—
—
43
155
545
5667
160
730
404
4869
Heart failure, unspecified
4289X [2000403703]
—
—
—
1.0e+50
—
2.5e+00
2.5e+00
—
—
—
—
—
—
cases:1.67%
controls:0.00%
—
—
cases:1.19%
controls:0.10%
cases:1.24%
controls:0.11%
—
—
—
10
0
588
5864
—
7
6
581
5816
7
6
557
5593
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
2.8e-01
4.4e-01
2.3e+00
—
2.6e+00
6.3e-01
3.5e-01
cases:2.85%
controls:2.17%
cases:1.84%
controls:1.19%
cases:1.34%
controls:0.14%
—
—
cases:1.52%
controls:0.12%
cases:2.21%
controls:1.19%
cases:3.72%
controls:2.64%
17
127
579
5724
11
70
587
5794
8
8
590
5856
—
9
7
585
5853
13
69
575
5753
21
148
543
5451
enalapril and diuretics
C09BA02 [21601804]
1.7e+00
1.5e+00
—
—
—
1.6e+00
1.5e+00
cases:1.34%
controls:0.26%
cases:1.34%
controls:0.31%
—
—
—
—
—
—
cases:1.87%
controls:0.38%
cases:4.79%
controls:1.09%
8
15
588
5836
8
18
590
5846
—
—
—
11
22
577
5800
27
61
537
5538
Chronic cardiac insufficiency
201 [2001600199]
1.4e+00
2.0e+00
—
—
—
—
1.3e+00
cases:2.35%
controls:0.56%
cases:1.00%
controls:0.14%
—
—
—
—
—
—
—
—
cases:2.13%
controls:0.57%
14
33
582
5818
6
8
592
5856
—
—
—
—
12
32
552
5567
Albumin [Mass/volume] in Urine
1754-1 [3012516]
2.4e+00
2.1e+00
1.0e+50
—
—
—
2.3e+00
cases:1.17%
controls:0.10%
cases:0.84%
controls:0.10%
cases:0.84%
controls:0.00%
—
—
—
—
—
—
cases:2.84%
controls:0.29%
7
6
589
5845
5
6
593
5858
5
0
593
5864
—
—
—
16
16
548
5583
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
2.1e-01
3.7e-01
2.3e+00
—
2.5e+00
7.7e-01
2.7e-01
cases:2.35%
controls:1.91%
cases:1.84%
controls:1.28%
cases:1.34%
controls:0.14%
—
—
cases:1.18%
controls:0.10%
cases:2.38%
controls:1.12%
cases:3.37%
controls:2.59%
14
112
582
5739
11
75
587
5789
8
8
590
5856
—
7
6
587
5854
14
65
574
5757
19
145
545
5454
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
-1.1e-04
3.8e-01
2.5e+00
1.0e+50
2.1e+00
2.4e-01
4.5e-02
cases:1.85%
controls:1.85%
cases:2.01%
controls:1.38%
cases:2.01%
controls:0.17%
cases:0.84%
controls:0.00%
cases:1.85%
controls:0.24%
cases:1.70%
controls:1.34%
cases:2.13%
controls:2.04%
11
108
585
5743
12
81
586
5783
12
10
586
5854
5
0
593
5864
11
14
583
5846
10
78
578
5744
12
114
552
5485
Essential (primary) hypertension
I10 [45591453]
1.2e+00
1.3e+00
—
1.0e+50
—
1.1e+00
8.9e-01
cases:4.36%
controls:1.42%
cases:2.34%
controls:0.63%
—
—
cases:1.34%
controls:0.00%
—
—
cases:3.06%
controls:1.00%
cases:8.87%
controls:3.86%
26
83
570
5768
14
37
584
5827
—
8
0
590
5864
—
18
58
570
5764
50
216
514
5383
losartan; oral
C09CA01 [21601824]
1.9e+00
1.5e+00
—
—
—
1.2e+00
1.1e+00
cases:1.85%
controls:0.29%
cases:1.51%
controls:0.32%
—
—
—
—
—
—
cases:1.36%
controls:0.43%
cases:2.84%
controls:1.00%
11
17
585
5834
9
19
589
5845
—
—
—
8
25
580
5797
16
56
548
5543
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]
4120X [2000403596]
1.0e+00
—
—
—
—
2.5e+00
2.0e+00
cases:0.84%
controls:0.31%
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.17%
cases:3.37%
controls:0.48%
5
18
591
5833
—
—
—
—
12
10
576
5812
19
27
545
5572
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
8.9e-02
1.1e-01
2.4e+00
1.0e+50
2.1e+00
2.7e-01
1.5e-01
cases:3.02%
controls:2.77%
cases:2.34%
controls:2.10%
cases:2.68%
controls:0.26%
cases:2.17%
controls:0.00%
cases:2.53%
controls:0.32%
cases:2.55%
controls:1.96%
cases:4.26%
controls:3.68%
18
162
578
5689
14
123
584
5741
16
15
582
5849
13
0
585
5864
15
19
579
5841
15
114
573
5708
24
206
540
5393
General Practice
1 [38004446]
6.3e-01
8.8e-01
—
—
2.2e+00
1.1e+00
1.1e+00
cases:3.19%
controls:1.73%
cases:2.68%
controls:1.13%
—
—
—
—
cases:1.68%
controls:0.19%
cases:4.25%
controls:1.41%
cases:17.38%
controls:6.63%
19
101
577
5750
16
66
582
5798
—
—
10
11
584
5849
25
82
563
5740
98
371
466
5228
Atherosclerotic heart disease
I25.1 [45596196]
1.5e+00
1.3e+00
-1.0e+50
—
—
1.8e+00
1.2e+00
cases:2.18%
controls:0.51%
cases:0.84%
controls:0.24%
cases:0.00%
controls:0.10%
—
—
—
—
cases:2.04%
controls:0.34%
cases:3.72%
controls:1.20%
13
30
583
5821
5
14
593
5850
0
6
598
5858
—
—
12
20
576
5802
21
67
543
5532
ramipril; oral
C09AA05 [21601789]
1.5e+00
1.4e+00
—
—
—
1.5e+00
7.5e-01
cases:2.52%
controls:0.60%
cases:2.17%
controls:0.55%
—
—
—
—
—
—
cases:2.89%
controls:0.65%
cases:2.84%
controls:1.36%
15
35
581
5816
13
32
585
5832
—
—
—
17
38
571
5784
16
76
548
5523
Albumin/Creatinine [Ratio] in Urine
32294-1 [3020682]
2.2e+00
2.1e+00
1.0e+50
—
—
—
2.2e+00
cases:1.17%
controls:0.14%
cases:0.84%
controls:0.10%
cases:1.00%
controls:0.00%
—
—
—
—
—
—
cases:2.66%
controls:0.30%
7
8
589
5843
5
6
593
5858
6
0
592
5864
—
—
—
15
17
549
5582
Triglyceride [Moles/volume] in Serum or Plasma
14927-8 [3025839]
1.9e+00
—
—
—
—
2.4e+00
6.7e-01
cases:1.34%
controls:0.21%
—
—
—
—
—
—
—
—
cases:1.53%
controls:0.14%
cases:1.42%
controls:0.73%
8
12
588
5839
—
—
—
—
9
8
579
5814
8
41
556
5558
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
-4.6e-02
6.2e-04
2.4e+00
1.0e+50
1.7e+00
2.8e-01
8.9e-03
cases:2.52%
controls:2.63%
cases:1.67%
controls:1.67%
cases:2.01%
controls:0.19%
cases:2.17%
controls:0.00%
cases:1.52%
controls:0.27%
cases:2.04%
controls:1.55%
cases:3.37%
controls:3.34%
15
154
581
5697
10
98
588
5766
12
11
586
5853
13
0
585
5864
9
16
585
5844
12
90
576
5732
19
187
545
5412
guar gum
A10BX01 [21600789]
—
—
—
—
—
—
4.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:9.22%
controls:0.18%
—
—
—
—
—
—
52
10
512
5589
Neurology
13 [38004458]
-2.4e-01
7.3e-01
—
1.0e+50
2.3e+00
9.5e-01
7.7e-01
cases:2.01%
controls:2.55%
cases:2.34%
controls:1.14%
—
—
cases:1.84%
controls:0.00%
cases:1.01%
controls:0.10%
cases:3.23%
controls:1.27%
cases:10.82%
controls:5.34%
12
149
584
5702
14
67
584
5797
—
11
0
587
5864
6
6
588
5854
19
74
569
5748
61
299
503
5300
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
206 [2001600204]
9.7e-01
1.1e+00
—
—
—
1.2e+00
7.5e-01
cases:7.05%
controls:2.79%
cases:2.84%
controls:1.01%
—
—
—
—
—
—
cases:2.04%
controls:0.60%
cases:5.85%
controls:2.86%
42
163
554
5688
17
59
581
5805
—
—
—
12
35
576
5787
33
160
531
5439
captopril; oral
C09AA01 [21601785]
1.4e+00
1.2e+00
—
—
2.1e+00
1.8e+00
2.1e+00
cases:1.01%
controls:0.24%
cases:0.84%
controls:0.26%
—
—
—
—
cases:0.84%
controls:0.10%
cases:2.04%
controls:0.33%
cases:6.21%
controls:0.77%
6
14
590
5837
5
15
593
5849
—
—
5
6
589
5854
12
19
576
5803
35
43
529
5556
Essential hypertension, Unspecified
4019X [2000403546]
5.6e-01
—
—
1.0e+50
—
2.3e+00
1.6e+00
cases:1.34%
controls:0.77%
—
—
—
—
cases:12.54%
controls:0.00%
—
—
cases:3.74%
controls:0.38%
cases:7.09%
controls:1.54%
8
45
588
5806
—
—
75
0
523
5864
—
22
22
566
5800
40
86
524
5513
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.8e-03
-6.7e-02
2.0e+00
1.0e+50
1.8e+00
3.3e-01
1.0e-01
cases:3.36%
controls:3.35%
cases:2.51%
controls:2.68%
cases:2.68%
controls:0.36%
cases:2.51%
controls:0.00%
cases:2.69%
controls:0.44%
cases:3.57%
controls:2.59%
cases:4.79%
controls:4.34%
20
196
576
5655
15
157
583
5707
16
21
582
5843
15
0
583
5864
16
26
578
5834
21
151
567
5671
27
243
537
5356
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-3.5e-03
-6.0e-02
2.0e+00
1.0e+50
1.8e+00
3.2e-01
9.8e-02
cases:3.36%
controls:3.37%
cases:2.51%
controls:2.66%
cases:2.68%
controls:0.36%
cases:2.51%
controls:0.00%
cases:2.69%
controls:0.44%
cases:3.57%
controls:2.61%
cases:4.79%
controls:4.36%
20
197
576
5654
15
156
583
5708
16
21
582
5843
15
0
583
5864
16
26
578
5834
21
152
567
5670
27
244
537
5355
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.8e-03
-6.7e-02
2.0e+00
1.0e+50
1.8e+00
3.3e-01
1.0e-01
cases:3.36%
controls:3.35%
cases:2.51%
controls:2.68%
cases:2.68%
controls:0.36%
cases:2.51%
controls:0.00%
cases:2.69%
controls:0.44%
cases:3.57%
controls:2.59%
cases:4.79%
controls:4.34%
20
196
576
5655
15
157
583
5707
16
21
582
5843
15
0
583
5864
16
26
578
5834
21
151
567
5671
27
243
537
5356
Platelets [#/volume] in Blood
26515-7 [3007461]
1.8e-03
-6.0e-02
2.0e+00
1.0e+50
1.8e+00
3.4e-01
1.0e-01
cases:3.36%
controls:3.35%
cases:2.51%
controls:2.66%
cases:2.68%
controls:0.36%
cases:2.51%
controls:0.00%
cases:2.69%
controls:0.44%
cases:3.57%
controls:2.58%
cases:4.79%
controls:4.34%
20
196
576
5655
15
156
583
5708
16
21
582
5843
15
0
583
5864
16
26
578
5834
21
150
567
5672
27
243
537
5356
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.8e-03
-6.0e-02
2.0e+00
1.0e+50
1.8e+00
3.3e-01
1.0e-01
cases:3.36%
controls:3.35%
cases:2.51%
controls:2.66%
cases:2.68%
controls:0.36%
cases:2.51%
controls:0.00%
cases:2.69%
controls:0.44%
cases:3.57%
controls:2.59%
cases:4.79%
controls:4.34%
20
196
576
5655
15
156
583
5708
16
21
582
5843
15
0
583
5864
16
26
578
5834
21
151
567
5671
27
243
537
5356
MCH [Entitic mass]
28539-5 [3035941]
1.8e-03
-6.7e-02
2.0e+00
1.0e+50
1.8e+00
3.3e-01
1.0e-01
cases:3.36%
controls:3.35%
cases:2.51%
controls:2.68%
cases:2.68%
controls:0.36%
cases:2.51%
controls:0.00%
cases:2.69%
controls:0.44%
cases:3.57%
controls:2.59%
cases:4.79%
controls:4.34%
20
196
576
5655
15
157
583
5707
16
21
582
5843
15
0
583
5864
16
26
578
5834
21
151
567
5671
27
243
537
5356
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.8e-03
-6.7e-02
2.0e+00
1.0e+50
1.8e+00
3.3e-01
1.0e-01
cases:3.36%
controls:3.35%
cases:2.51%
controls:2.68%
cases:2.68%
controls:0.36%
cases:2.51%
controls:0.00%
cases:2.69%
controls:0.46%
cases:3.57%
controls:2.59%
cases:4.79%
controls:4.34%
20
196
576
5655
15
157
583
5707
16
21
582
5843
15
0
583
5864
16
27
578
5833
21
151
567
5671
27
243
537
5356
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-1.0e-01
-1.4e-01
1.9e+00
1.0e+50
2.0e+00
1.9e-01
1.9e-01
cases:2.35%
controls:2.60%
cases:1.67%
controls:1.91%
cases:1.51%
controls:0.24%
cases:2.01%
controls:0.00%
cases:1.68%
controls:0.24%
cases:2.21%
controls:1.84%
cases:3.90%
controls:3.25%
14
152
582
5699
10
112
588
5752
9
14
589
5850
12
0
586
5864
10
14
584
5846
13
107
575
5715
22
182
542
5417
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-1.2e-01
-1.5e-01
1.9e+00
1.0e+50
1.9e+00
2.9e-01
1.2e-01
cases:2.18%
controls:2.44%
cases:1.84%
controls:2.13%
cases:1.51%
controls:0.24%
cases:1.84%
controls:0.00%
cases:1.85%
controls:0.29%
cases:2.38%
controls:1.79%
cases:3.01%
controls:2.68%
13
143
583
5708
11
125
587
5739
9
14
589
5850
11
0
587
5864
11
17
583
5843
14
104
574
5718
17
150
547
5449
Pharmacy visit
OMOP4822462 [581458]
1.8e-01
3.8e-01
8.5e-01
1.1e+00
1.2e+00
5.2e-01
7.1e-01
cases:33.72%
controls:29.89%
cases:38.46%
controls:29.91%
cases:26.25%
controls:13.23%
cases:1.67%
controls:0.55%
cases:35.02%
controls:13.65%
cases:49.15%
controls:36.41%
cases:82.45%
controls:69.71%
201
1749
395
4102
230
1754
368
4110
157
776
441
5088
10
32
588
5832
208
800
386
5060
289
2120
299
3702
465
3903
99
1696
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
4.5e-01
5.9e-01
2.5e+00
—
—
1.0e+00
6.2e-01
cases:2.85%
controls:1.85%
cases:1.84%
controls:1.02%
cases:1.51%
controls:0.12%
—
—
—
—
cases:2.72%
controls:1.00%
cases:4.08%
controls:2.23%
17
108
579
5743
11
60
587
5804
9
7
589
5857
—
—
16
58
572
5764
23
125
541
5474
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
6.1e-02
8.8e-02
1.9e+00
1.0e+50
1.7e+00
1.4e-01
1.3e-01
cases:2.68%
controls:2.53%
cases:2.17%
controls:2.00%
cases:1.84%
controls:0.29%
cases:0.84%
controls:0.00%
cases:1.35%
controls:0.26%
cases:2.04%
controls:1.79%
cases:3.90%
controls:3.45%
16
148
580
5703
13
117
585
5747
11
17
587
5847
5
0
593
5864
8
15
586
5845
12
104
576
5718
22
193
542
5406
Cardiac dysrhythmias, Atrial fibrillation and flutter
4273A [2000403694]
7.9e-01
—
—
1.0e+50
—
2.0e+00
1.5e+00
cases:1.01%
controls:0.46%
—
—
—
—
cases:2.51%
controls:0.00%
—
—
cases:1.53%
controls:0.21%
cases:3.90%
controls:0.91%
6
27
590
5824
—
—
15
0
583
5864
—
9
12
579
5810
22
51
542
5548
calcium carbonate
A02AC01 [21600065]
—
1.0e+50
—
—
—
1.0e+50
3.5e+00
—
—
cases:1.84%
controls:0.00%
—
—
—
—
—
—
cases:2.38%
controls:0.00%
cases:2.84%
controls:0.09%
—
11
0
587
5864
—
—
—
14
0
574
5822
16
5
548
5594
calcium carbonate; oral
A12AA04 [21600863]
—
1.0e+50
—
—
—
1.0e+50
3.5e+00
—
—
cases:1.84%
controls:0.00%
—
—
—
—
—
—
cases:2.38%
controls:0.00%
cases:2.84%
controls:0.09%
—
11
0
587
5864
—
—
—
14
0
574
5822
16
5
548
5594
Atherosclerosis, Of native arteries of the extremities
4402A [2000403762]
1.4e+00
—
—
—
—
—
3.5e+00
cases:1.01%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:4.96%
controls:0.16%
6
15
590
5836
—
—
—
—
—
28
9
536
5590
miconazole
D01AC02 [21601921]
—
2.1e+00
—
—
—
1.6e+00
1.3e+00
—
—
cases:1.00%
controls:0.12%
—
—
—
—
—
—
cases:1.02%
controls:0.21%
cases:4.08%
controls:1.16%
—
6
7
592
5857
—
—
—
6
12
582
5810
23
65
541
5534
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
5.7e-01
6.0e-01
2.4e+00
—
—
1.0e+00
5.4e-01
cases:3.19%
controls:1.83%
cases:2.01%
controls:1.11%
cases:1.51%
controls:0.14%
—
—
—
—
cases:2.72%
controls:1.01%
cases:3.90%
controls:2.30%
19
107
577
5744
12
65
586
5799
9
8
589
5856
—
—
16
59
572
5763
22
129
542
5470
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
7.2e-01
4.9e-01
—
—
—
1.7e+00
1.7e+00
cases:2.35%
controls:1.16%
cases:0.84%
controls:0.51%
—
—
—
—
—
—
cases:1.87%
controls:0.34%
cases:11.70%
controls:2.45%
14
68
582
5783
5
30
593
5834
—
—
—
11
20
577
5802
66
137
498
5462
lovastatin; oral
C10AA02 [21601857]
1.3e+00
1.7e+00
—
—
—
1.9e+00
1.4e+00
cases:0.84%
controls:0.24%
cases:1.00%
controls:0.19%
—
—
—
—
—
—
cases:1.87%
controls:0.29%
cases:4.61%
controls:1.21%
5
14
591
5837
6
11
592
5853
—
—
—
11
17
577
5805
26
68
538
5531
furosemide and potassium-sparing agents
C03EB01 [21601554]
1.1e+00
1.2e+00
—
—
—
1.0e+00
9.5e-01
cases:2.01%
controls:0.67%
cases:2.34%
controls:0.73%
—
—
—
—
—
—
cases:2.38%
controls:0.86%
cases:5.50%
controls:2.20%
12
39
584
5812
14
43
584
5821
—
—
—
14
50
574
5772
31
123
533
5476
isosorbide dinitrate; local oral, oral, sublingual, transdermal
C01DA08 [21600321]
4.4e-01
1.0e+00
8.5e-01
—
1.4e+00
1.0e+00
1.1e+00
cases:2.18%
controls:1.42%
cases:3.34%
controls:1.24%
cases:0.84%
controls:0.36%
—
—
cases:1.52%
controls:0.39%
cases:4.08%
controls:1.51%
cases:12.94%
controls:4.57%
13
83
583
5768
20
73
578
5791
5
21
593
5843
—
9
23
585
5837
24
88
564
5734
73
256
491
5343
dipyridamole; oral, parenteral
B01AC07 [21600992]
—
—
—
—
—
1.7e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:2.55%
controls:0.46%
cases:6.03%
controls:1.52%
—
—
—
—
—
15
27
573
5795
34
85
530
5514
Photography of fundus of eye
XCK10 [2001301381]
—
—
—
—
—
—
3.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.84%
controls:0.13%
—
—
—
—
—
—
16
7
548
5592
prednisolone; oral, parenteral
H02AB06 [21602734]
3.8e-01
8.9e-01
1.8e+00
—
2.5e+00
7.8e-01
6.9e-01
cases:2.52%
controls:1.74%
cases:2.17%
controls:0.90%
cases:1.17%
controls:0.20%
—
—
cases:1.18%
controls:0.10%
cases:2.55%
controls:1.19%
cases:6.74%
controls:3.48%
15
102
581
5749
13
53
585
5811
7
12
591
5852
—
7
6
587
5854
15
69
573
5753
38
195
526
5404
prednisolone
A07EA01 [21600653]
3.7e-01
8.9e-01
1.8e+00
—
2.5e+00
7.8e-01
6.8e-01
cases:2.52%
controls:1.76%
cases:2.17%
controls:0.90%
cases:1.17%
controls:0.20%
—
—
cases:1.18%
controls:0.10%
cases:2.55%
controls:1.19%
cases:6.74%
controls:3.52%
15
103
581
5748
13
53
585
5811
7
12
591
5852
—
7
6
587
5854
15
69
573
5753
38
197
526
5402
spironolactone; oral
C03DA01 [21601534]
2.0e+00
—
—
—
—
—
1.1e+00
cases:1.51%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:2.30%
controls:0.79%
9
12
587
5839
—
—
—
—
—
13
44
551
5555
Nephrology
39 [38004479]
—
—
—
1.0e+50
1.0e+50
—
3.1e+00
—
—
—
—
—
—
cases:1.67%
controls:0.00%
cases:1.52%
controls:0.00%
—
—
cases:3.37%
controls:0.16%
—
—
—
10
0
588
5864
9
0
585
5860
—
19
9
545
5590
Angina pectoris, Angina decubitus[ANGINA PECTORIS ("EFFORT ANGINA"),MÄÄRITTELEMÄT]
4130X [2000403609]
4.3e-01
—
-1.0e+50
1.0e+50
—
1.6e+00
1.5e+00
cases:0.84%
controls:0.55%
—
—
cases:0.00%
controls:0.09%
cases:1.84%
controls:0.00%
—
—
cases:1.87%
controls:0.40%
cases:4.08%
controls:0.95%
5
32
591
5819
—
0
5
598
5859
11
0
587
5864
—
11
23
577
5799
23
53
541
5546
ciclosporin; oral, parenteral
L04AD01 [21603924]
—
—
—
—
—
—
2.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.60%
controls:0.09%
—
—
—
—
—
—
9
5
555
5594
Laboratory Visit
OMOP4822461 [32036]
-7.4e-02
-1.0e-01
1.5e+00
1.0e+50
1.4e+00
1.2e-01
4.6e-02
cases:3.69%
controls:3.97%
cases:3.18%
controls:3.51%
cases:3.18%
controls:0.73%
cases:2.68%
controls:0.00%
cases:3.54%
controls:0.92%
cases:3.91%
controls:3.47%
cases:5.32%
controls:5.09%
22
232
574
5619
19
206
579
5658
19
43
579
5821
16
0
582
5864
21
54
573
5806
23
202
565
5620
30
285
534
5314
alfacalcidol; oral, parenteral
A11CC03 [21600818]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.30%
controls:0.14%
—
—
—
—
—
—
13
8
551
5591
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
—
—
—
—
—
1.3e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:2.21%
controls:0.62%
cases:7.98%
controls:1.89%
—
—
—
—
—
13
36
575
5786
45
106
519
5493
nifedipine; oral, parenteral
C08CA05 [21601751]
1.1e+00
1.5e+00
—
—
—
1.3e+00
7.5e-01
cases:1.34%
controls:0.46%
cases:2.17%
controls:0.51%
—
—
—
—
—
—
cases:2.89%
controls:0.82%
cases:4.26%
controls:2.05%
8
27
588
5824
13
30
585
5834
—
—
—
17
48
571
5774
24
115
540
5484
Supplier / Service Provider
OMOP5117446 [33004]
-1.5e+00
-1.1e+00
—
—
—
—
5.3e+00
cases:6.71%
controls:24.00%
cases:3.18%
controls:9.12%
—
—
—
—
—
—
—
—
cases:24.65%
controls:0.16%
40
1404
556
4447
19
535
579
5329
—
—
—
—
139
9
425
5590
Handing over of treatment supplies
SPAT1262 [2001700363]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.77%
controls:0.13%
—
—
—
—
—
—
10
7
554
5592
bezafibrate; oral
C10AB02 [21601866]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.19%
controls:0.23%
—
—
—
—
—
—
18
13
546
5586
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
4.2e-01
2.7e-01
—
—
2.6e+00
7.7e-01
4.7e-01
cases:2.68%
controls:1.78%
cases:1.34%
controls:1.02%
—
—
—
—
cases:1.18%
controls:0.09%
cases:1.87%
controls:0.88%
cases:3.19%
controls:2.02%
16
104
580
5747
8
60
590
5804
—
—
7
5
587
5855
11
51
577
5771
18
113
546
5486
acetylsalicylic acid; oral
B01AC06 [21600991]
4.6e-01
3.4e-01
—
—
—
1.2e+00
1.3e+00
cases:0.84%
controls:0.53%
cases:0.84%
controls:0.60%
—
—
—
—
—
—
cases:2.55%
controls:0.76%
cases:8.16%
controls:2.27%
5
31
591
5820
5
35
593
5829
—
—
—
15
44
573
5778
46
127
518
5472
warfarin; oral, parenteral
B01AA03 [21600965]
6.4e-01
8.0e-01
—
—
1.7e+00
1.2e+00
1.3e+00
cases:1.68%
controls:0.89%
cases:1.84%
controls:0.84%
—
—
—
—
cases:1.01%
controls:0.19%
cases:3.23%
controls:1.00%
cases:9.40%
controls:2.75%
10
52
586
5799
11
49
587
5815
—
—
6
11
588
5849
19
58
569
5764
53
154
511
5445
Acute myocardial infarction, unspecified
I21.9 [45605780]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.09%
—
—
—
—
—
—
6
5
558
5594
Symptomatic heart disease, Congestive heart failure
42700 [2000302625]
2.5e+00
—
—
—
—
—
—
cases:1.01%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
590
5846
—
—
—
—
—
—
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
1.8e-01
2.3e-01
2.4e+00
—
1.8e+00
7.6e-01
3.6e-01
cases:1.68%
controls:1.40%
cases:1.00%
controls:0.80%
cases:1.17%
controls:0.10%
—
—
cases:0.84%
controls:0.14%
cases:1.53%
controls:0.72%
cases:2.13%
controls:1.50%
10
82
586
5769
6
47
592
5817
7
6
591
5858
—
5
8
589
5852
9
42
579
5780
12
84
552
5515
Erysipelas[ERYSIPELAS ALIA DEFINITA SEU NUD]
0350X [2000400419]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.13%
—
—
—
—
—
—
8
7
556
5592
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
9.2e-01
1.1e+00
—
—
1.8e+00
1.6e+00
7.7e-01
cases:2.85%
controls:1.16%
cases:1.84%
controls:0.60%
—
—
—
—
cases:0.84%
controls:0.14%
cases:3.57%
controls:0.74%
cases:5.50%
controls:2.63%
17
68
579
5783
11
35
587
5829
—
—
5
8
589
5852
21
43
567
5779
31
147
533
5452
Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]
4029A [2000403548]
—
—
—
1.0e+50
—
—
2.3e+00
—
—
—
—
—
—
cases:1.67%
controls:0.00%
—
—
—
—
cases:1.42%
controls:0.14%
—
—
—
10
0
588
5864
—
—
8
8
556
5591
Vascular Surgery
77 [38004496]
2.3e+00
—
—
—
—
—
1.3e+00
cases:1.17%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.39%
7
7
589
5844
—
—
—
—
—
8
22
556
5577
Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]
4148X [2000403628]
-1.0e+50
—
—
1.0e+50
—
—
2.3e+00
cases:0.00%
controls:0.22%
—
—
—
—
cases:1.67%
controls:0.00%
—
—
—
—
cases:3.19%
controls:0.34%
0
13
596
5838
—
—
10
0
588
5864
—
—
18
19
546
5580
atorvastatin; oral
C10AA05 [21601860]
9.3e-01
1.0e+00
—
—
—
1.2e+00
1.1e+00
cases:2.68%
controls:1.08%
cases:2.01%
controls:0.73%
—
—
—
—
—
—
cases:2.55%
controls:0.81%
cases:6.03%
controls:2.13%
16
63
580
5788
12
43
586
5821
—
—
—
15
47
573
5775
34
119
530
5480
Other healthcare associate professional
Z3229 [2001311561]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.16%
—
—
—
—
—
—
8
9
556
5590
Chronic disorders of vitamin D metabolism
123 [2001600122]
1.0e+50
—
—
—
—
—
2.2e+00
cases:1.51%
controls:0.00%
—
—
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.16%
9
0
587
5851
—
—
—
—
—
8
9
556
5590
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
—
—
—
—
—
2.2e+00
5.8e-01
—
—
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.15%
cases:0.89%
controls:0.50%
—
—
—
—
—
8
9
580
5813
5
28
559
5571
Observation for other suspected diseases and conditions
Z03.89 [2000503757]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.14%
—
—
—
—
—
—
7
8
557
5591
acebutolol; oral, parenteral
C07AB04 [21601686]
2.2e+00
1.5e+00
—
—
—
1.4e+00
8.3e-01
cases:1.17%
controls:0.14%
cases:0.84%
controls:0.19%
—
—
—
—
—
—
cases:0.85%
controls:0.21%
cases:1.42%
controls:0.63%
7
8
589
5843
5
11
593
5853
—
—
—
5
12
583
5810
8
35
556
5564
Other chronic renal failure
N18.8 [45534123]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.13%
—
—
—
—
—
—
6
7
558
5592
Esophagogastroduodenoscopy (also includes staining)
1300 [2000100125]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.13%
—
—
—
—
—
—
6
7
558
5592
Chronic kidney disease
N18 [45582391]
1.0e+50
1.0e+50
—
—
—
—
2.1e+00
cases:1.17%
controls:0.00%
cases:1.00%
controls:0.00%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.13%
7
0
589
5851
6
0
592
5864
—
—
—
—
6
7
558
5592
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
2402 [2000100276]
2.1e+00
—
—
—
—
—
—
cases:1.01%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
590
5844
—
—
—
—
—
—
Other angina pectoris stenosed coronary artery
I20.81 [2000502397]
2.1e+00
—
—
—
—
—
9.5e-01
cases:1.01%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.55%
6
7
590
5844
—
—
—
—
—
8
31
556
5568
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
3.1e-01
-1.0e+50
—
—
—
2.1e+00
8.3e-01
cases:0.84%
controls:0.62%
cases:0.00%
controls:0.17%
—
—
—
—
—
—
cases:1.36%
controls:0.17%
cases:1.42%
controls:0.63%
5
36
591
5815
0
10
598
5854
—
—
—
8
10
580
5812
8
35
556
5564
Ambulatory ECG
XF404 [2001303370]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.16%
—
—
—
—
—
—
7
9
557
5590
alprostadil; parenteral
C01EA01 [21600362]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.13%
controls:0.29%
—
—
—
—
—
—
12
16
552
5583
Bypass surgery using a mammary artery
5315 [2000100733]
—
—
—
—
—
1.0e+50
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:2.21%
controls:0.00%
cases:2.13%
controls:0.29%
—
—
—
—
—
13
0
575
5822
12
16
552
5583
alprostadil; implant, parenteral
G04BE01 [21602646]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.13%
controls:0.29%
—
—
—
—
—
—
12
16
552
5583
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.14%
—
—
—
—
—
—
6
8
558
5591
tolterodine; oral
G04BD07 [21602640]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.14%
—
—
—
—
—
—
6
8
558
5591
Emergency Room and Inpatient Visit
ERIP [262]
7.6e-01
1.3e+00
—
1.0e+50
—
2.0e+00
5.1e-01
cases:0.84%
controls:0.39%
cases:1.00%
controls:0.27%
—
—
cases:1.34%
controls:0.00%
—
—
cases:1.02%
controls:0.14%
cases:1.06%
controls:0.64%
5
23
591
5828
6
16
592
5848
—
8
0
590
5864
—
6
8
582
5814
6
36
558
5563
Chronic kidney disease, unspecified
N18.9 [45553438]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.20%
—
—
—
—
—
—
8
11
556
5588
Angina pectoris, Angina decubitus[ANGINA PECTORIS ("EFFORT ANGINA"),AHTAUTUNUT]
4130B [2000403605]
-1.0e+50
—
—
1.0e+50
—
1.0e+50
2.0e+00
cases:0.00%
controls:0.21%
—
—
—
—
cases:1.17%
controls:0.00%
—
—
cases:2.38%
controls:0.00%
cases:3.72%
controls:0.54%
0
12
596
5839
—
—
7
0
591
5864
—
14
0
574
5822
21
30
543
5569
Bypass surgery for three vessels
5313 [2000100731]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.18%
—
—
—
—
—
—
7
10
557
5589
Infectious Disease
44 [38004484]
1.3e+00
—
—
—
—
—
1.9e+00
cases:0.84%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:1.60%
controls:0.23%
5
13
591
5838
—
—
—
—
—
9
13
555
5586
CBC panel - Blood by Automated count
58410-2 [40761511]
-6.9e-02
2.3e-01
1.8e+00
1.0e+50
1.9e+00
1.8e-01
1.0e-01
cases:2.68%
controls:2.87%
cases:2.01%
controls:1.60%
cases:1.17%
controls:0.20%
cases:1.34%
controls:0.00%
cases:1.52%
controls:0.22%
cases:1.70%
controls:1.43%
cases:3.72%
controls:3.38%
16
168
580
5683
12
94
586
5770
7
12
591
5852
8
0
590
5864
9
13
585
5847
10
83
578
5739
21
189
543
5410
Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,AHTAUTUNUT]
4140B [2000403618]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.13%
controls:0.32%
—
—
—
—
—
—
12
18
552
5581
yohimbine; oral
G04BE04 [21602649]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.77%
controls:0.27%
—
—
—
—
—
—
10
15
554
5584
Observation for suspected nervous system disorder
Z03.3 [45609903]
-1.0e+50
—
—
—
—
—
1.9e+00
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.20%
0
8
596
5843
—
—
—
—
—
7
11
557
5588
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
-1.0e+50
—
—
—
—
—
1.8e+00
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.77%
controls:0.29%
0
6
596
5845
—
—
—
—
—
10
16
554
5583
potassium chloride; oral
A12BA01 [21600877]
1.6e+00
—
—
—
—
1.7e+00
1.8e+00
cases:0.84%
controls:0.17%
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.19%
cases:3.90%
controls:0.66%
5
10
591
5841
—
—
—
—
6
11
582
5811
22
37
542
5562
Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,MÄÄRITTELEMÄT]
4140X [2000403622]
-1.0e+50
—
—
—
—
—
1.8e+00
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:1.77%
controls:0.30%
0
5
596
5846
—
—
—
—
—
10
17
554
5582
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
4.3e-01
5.6e-01
—
—
—
1.7e+00
8.2e-01
cases:1.17%
controls:0.77%
cases:0.84%
controls:0.48%
—
—
—
—
—
—
cases:1.36%
controls:0.24%
cases:1.77%
controls:0.79%
7
45
589
5806
5
28
593
5836
—
—
—
8
14
580
5808
10
44
554
5555
Examination of eyes and vision
Z01.0 [45566391]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.30%
controls:0.41%
—
—
—
—
—
—
13
23
551
5576
Bypass surgery for four or more vessels
5314 [2000100732]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.60%
controls:0.30%
—
—
—
—
—
—
9
17
555
5582
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.13%
controls:0.41%
—
—
—
—
—
—
12
23
552
5576
Angina pectoris, Without mention of hypertensive disease
41399 [2000302585]
1.7e+00
—
—
—
—
—
—
cases:1.51%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
9
17
587
5834
—
—
—
—
—
—
amlodipine; oral
C08CA01 [21601747]
9.6e-01
9.0e-01
1.3e+00
—
9.1e-01
8.6e-01
7.0e-01
cases:3.02%
controls:1.18%
cases:2.51%
controls:1.04%
cases:1.34%
controls:0.36%
—
—
cases:0.84%
controls:0.34%
cases:2.72%
controls:1.17%
cases:5.32%
controls:2.71%
18
69
578
5782
15
61
583
5803
8
21
590
5843
—
5
20
589
5840
16
68
572
5754
30
152
534
5447
econazole; vaginal
G01AF05 [21602395]
—
-1.0e+50
—
—
—
—
1.7e+00
—
—
cases:0.00%
controls:0.19%
—
—
—
—
—
—
—
—
cases:3.37%
controls:0.66%
—
0
11
598
5853
—
—
—
—
19
37
545
5562
econazole
D01AC03 [21601922]
—
-1.0e+50
—
—
—
—
1.6e+00
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
cases:3.19%
controls:0.64%
—
0
10
598
5854
—
—
—
—
18
36
546
5563
celiprolol; oral
C07AB08 [21601690]
—
-1.0e+50
—
—
—
—
1.6e+00
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
cases:2.66%
controls:0.54%
—
0
10
598
5854
—
—
—
—
15
30
549
5569
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
3.7e-01
9.5e-01
1.0e+50
1.0e+50
—
1.6e+00
8.9e-01
cases:1.68%
controls:1.16%
cases:1.00%
controls:0.39%
cases:1.00%
controls:0.00%
cases:1.34%
controls:0.00%
—
—
cases:1.87%
controls:0.38%
cases:2.66%
controls:1.11%
10
68
586
5783
6
23
592
5841
6
0
592
5864
8
0
590
5864
—
11
22
577
5800
15
62
549
5537
Chronic asthma and similar chronic obstructive pulmonary diseases
203 [2001600201]
2.1e-01
—
—
—
—
1.6e+00
-3.2e-01
cases:1.51%
controls:1.23%
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.27%
cases:1.24%
controls:1.70%
9
72
587
5779
—
—
—
—
8
16
580
5806
7
95
557
5504
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
1.3e+00
—
—
—
—
—
1.6e+00
cases:1.17%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:2.13%
controls:0.45%
7
19
589
5832
—
—
—
—
—
12
25
552
5574
Angiography of the heart and coronary arteries
81 [2002100125]
1.3e+00
—
—
—
—
—
1.6e+00
cases:1.01%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:2.84%
controls:0.61%
6
16
590
5835
—
—
—
—
—
16
34
548
5565
gemfibrozil; oral
C10AB04 [21601868]
—
—
—
—
—
2.1e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.10%
cases:1.95%
controls:0.43%
—
—
—
—
—
5
6
583
5816
11
24
553
5575
methenamine; oral
J01XX05 [21603065]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.95%
controls:0.43%
—
—
—
—
—
—
11
24
553
5575
zopiclone; oral
N05CF01 [21604654]
6.6e-01
5.0e-01
9.5e-01
—
1.3e+00
8.8e-01
6.4e-01
cases:3.36%
controls:1.76%
cases:2.68%
controls:1.64%
cases:1.00%
controls:0.39%
—
—
cases:1.01%
controls:0.29%
cases:4.25%
controls:1.80%
cases:10.64%
controls:5.91%
20
103
576
5748
16
96
582
5768
6
23
592
5841
—
6
17
588
5843
25
105
563
5717
60
331
504
5268
dextropropoxyphene; oral
N02AC04 [21604278]
—
—
—
—
—
1.1e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.29%
cases:4.08%
controls:0.93%
—
—
—
—
—
5
17
583
5805
23
52
541
5547
Medical doctor
Z2221 [2001311556]
6.0e-01
1.3e+00
—
—
—
1.5e+00
1.1e+00
cases:1.17%
controls:0.65%
cases:1.17%
controls:0.32%
—
—
—
—
—
—
cases:1.53%
controls:0.34%
cases:2.13%
controls:0.75%
7
38
589
5813
7
19
591
5845
—
—
—
9
20
579
5802
12
42
552
5557
clopidogrel; oral
B01AC04 [21600989]
—
—
-1.0e+50
—
—
1.7e+00
1.5e+00
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
cases:1.02%
controls:0.19%
cases:2.13%
controls:0.48%
—
—
0
5
598
5859
—
—
6
11
582
5811
12
27
552
5572
ofloxacin; oral, parenteral
J01MA01 [21603008]
—
—
—
—
—
1.3e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.22%
cases:3.72%
controls:0.89%
—
—
—
—
—
5
13
583
5809
21
50
543
5549
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
7.3e-01
7.3e-01
—
—
—
6.4e-01
1.4e+00
cases:2.85%
controls:1.40%
cases:1.34%
controls:0.65%
—
—
—
—
—
—
cases:1.36%
controls:0.72%
cases:7.80%
controls:1.96%
17
82
579
5769
8
38
590
5826
—
—
—
8
42
580
5780
44
110
520
5489
Essential benign hypertension
40199 [2000302561]
1.4e+00
—
—
—
—
—
—
cases:2.01%
controls:0.50%
—
—
—
—
—
—
—
—
—
—
—
—
12
29
584
5822
—
—
—
—
—
—
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician
208G00000X [38004023]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.19%
controls:0.82%
—
—
—
—
—
—
18
46
546
5553
Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]
4100X [2000403564]
—
—
—
1.0e+50
—
1.8e+00
1.4e+00
—
—
—
—
—
—
cases:3.18%
controls:0.00%
—
—
cases:0.85%
controls:0.14%
cases:2.84%
controls:0.75%
—
—
—
19
0
579
5864
—
5
8
583
5814
16
42
548
5557
nitrofurantoin; oral
J01XE01 [21603058]
6.8e-01
—
—
—
—
—
1.3e+00
cases:0.84%
controls:0.43%
—
—
—
—
—
—
—
—
—
—
cases:3.72%
controls:1.02%
5
25
591
5826
—
—
—
—
—
21
57
543
5542
Chronic ischaemic heart disease, unspecified
I25.9 [45552784]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.13%
controls:0.61%
—
—
—
—
—
—
12
34
552
5565
Cataract, Senile cataract
3661A [2000403305]
6.8e-01
—
—
—
—
—
1.3e+00
cases:0.84%
controls:0.43%
—
—
—
—
—
—
—
—
—
—
cases:2.48%
controls:0.71%
5
25
591
5826
—
—
—
—
—
14
40
550
5559
lisinopril; oral
C09AA03 [21601787]
1.6e+00
1.7e+00
—
—
—
1.5e+00
1.3e+00
cases:0.84%
controls:0.17%
cases:1.17%
controls:0.22%
—
—
—
—
—
—
cases:1.36%
controls:0.31%
cases:3.01%
controls:0.88%
5
10
591
5841
7
13
591
5851
—
—
—
8
18
580
5804
17
49
547
5550
Chronic hypertension
205 [2001600203]
3.6e-01
7.0e-01
—
—
2.0e+00
1.2e+00
5.7e-01
cases:5.20%
controls:3.67%
cases:1.84%
controls:0.92%
—
—
—
—
cases:0.84%
controls:0.12%
cases:2.72%
controls:0.81%
cases:5.85%
controls:3.41%
31
215
565
5636
11
54
587
5810
—
—
5
7
589
5853
16
47
572
5775
33
191
531
5408
s-atenolol; oral
C07AB11 [21601693]
1.2e+00
1.1e+00
—
—
—
9.0e-01
5.9e-01
cases:2.01%
controls:0.60%
cases:1.84%
controls:0.65%
—
—
—
—
—
—
cases:2.21%
controls:0.91%
cases:4.96%
controls:2.80%
12
35
584
5816
11
38
587
5826
—
—
—
13
53
575
5769
28
157
536
5442
atenolol; oral, parenteral
C07AB03 [21601685]
1.2e+00
1.1e+00
—
—
—
9.0e-01
5.9e-01
cases:2.01%
controls:0.60%
cases:1.84%
controls:0.65%
—
—
—
—
—
—
cases:2.21%
controls:0.91%
cases:4.96%
controls:2.80%
12
35
584
5816
11
38
587
5826
—
—
—
13
53
575
5769
28
157
536
5442
amitriptyline; oral, parenteral
N06AA09 [21604696]
8.0e-01
—
-1.0e+50
—
—
1.4e+00
1.2e+00
cases:1.17%
controls:0.53%
—
—
cases:0.00%
controls:0.09%
—
—
—
—
cases:1.02%
controls:0.26%
cases:3.55%
controls:1.07%
7
31
589
5820
—
0
5
598
5859
—
—
6
15
582
5807
20
60
544
5539
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
8.2e-01
—
—
—
—
—
1.2e+00
cases:1.01%
controls:0.44%
—
—
—
—
—
—
—
—
—
—
cases:2.13%
controls:0.64%
6
26
590
5825
—
—
—
—
—
12
36
552
5563
Sleep apnoea
G47.3 [45562094]
—
—
—
—
—
1.2e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.26%
cases:2.30%
controls:0.71%
—
—
—
—
—
5
15
583
5807
13
40
551
5559
norfloxacin; oral
J01MA06 [21603013]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.01%
controls:0.95%
—
—
—
—
—
—
17
53
547
5546
erythromycin; oral, parenteral
J01FA01 [21602970]
9.0e-01
—
—
—
—
1.1e+00
1.2e+00
cases:0.84%
controls:0.34%
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.33%
cases:2.48%
controls:0.79%
5
20
591
5831
—
—
—
—
6
19
582
5803
14
44
550
5555
sucralfate; oral
A02BX02 [21600111]
—
—
—
—
—
1.7e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.15%
cases:2.84%
controls:0.91%
—
—
—
—
—
5
9
583
5813
16
51
548
5548
One hour or less
ZXE00 [2001311394]
5.0e-01
1.4e+00
—
—
—
1.4e+00
1.2e+00
cases:2.01%
controls:1.23%
cases:1.34%
controls:0.32%
—
—
—
—
—
—
cases:1.36%
controls:0.34%
cases:4.96%
controls:1.63%
12
72
584
5779
8
19
590
5845
—
—
—
8
20
580
5802
28
91
536
5508
Physical Medicine And Rehabilitation
25 [38004468]
6.4e-01
—
-1.0e+50
—
—
8.8e-01
1.1e+00
cases:2.01%
controls:1.08%
—
—
cases:0.00%
controls:0.10%
—
—
—
—
cases:1.19%
controls:0.50%
cases:4.43%
controls:1.48%
12
63
584
5788
—
0
6
598
5858
—
—
7
29
581
5793
25
83
539
5516
carbamazepine; oral, rectal
N03AF01 [21604417]
—
—
—
—
-1.0e+50
8.6e-01
1.1e+00
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
cases:0.85%
controls:0.36%
cases:2.48%
controls:0.82%
—
—
—
—
0
5
594
5855
5
21
583
5801
14
46
550
5553
Cardiology
6 [38004451]
5.9e-01
1.2e+00
-1.0e+50
—
—
1.2e+00
1.1e+00
cases:1.68%
controls:0.94%
cases:1.51%
controls:0.46%
cases:0.00%
controls:0.09%
—
—
—
—
cases:2.04%
controls:0.62%
cases:5.14%
controls:1.79%
10
55
586
5796
9
27
589
5837
0
5
598
5859
—
—
12
36
576
5786
29
100
535
5499
More than one and less than three hours
ZXE10 [2001311401]
6.0e-01
—
—
—
—
9.6e-01
1.1e+00
cases:1.51%
controls:0.84%
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.33%
cases:3.37%
controls:1.16%
9
49
587
5802
—
—
—
—
5
19
583
5803
19
65
545
5534
trimethoprim; oral, parenteral
J01EA01 [21602931]
6.4e-01
9.8e-01
—
—
—
4.8e-01
1.1e+00
cases:2.18%
controls:1.16%
cases:1.67%
controls:0.63%
—
—
—
—
—
—
cases:1.19%
controls:0.74%
cases:8.51%
controls:3.13%
13
68
583
5783
10
37
588
5827
—
—
—
7
43
581
5779
48
175
516
5424
miconazole
S02AA13 [21605159]
—
—
—
—
—
1.7e+00
1.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.15%
cases:2.48%
controls:0.88%
—
—
—
—
—
5
9
583
5813
14
49
550
5550
Glaucoma
114 [2001600114]
—
-1.0e+50
—
—
—
—
1.1e+00
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
cases:2.48%
controls:0.88%
—
0
6
598
5858
—
—
—
—
14
49
550
5550
cefadroxil; oral
J01DB05 [21602874]
2.1e-01
7.2e-01
—
—
—
—
1.0e+00
cases:1.01%
controls:0.82%
cases:0.84%
controls:0.41%
—
—
—
—
—
—
—
—
cases:6.74%
controls:2.57%
6
48
590
5803
5
24
593
5840
—
—
—
—
38
144
526
5455
Thorax X-ray examination
GD1AA [2001303617]
5.5e-01
1.3e+00
—
—
—
1.6e+00
9.8e-01
cases:1.17%
controls:0.68%
cases:0.84%
controls:0.24%
—
—
—
—
—
—
cases:1.19%
controls:0.24%
cases:3.37%
controls:1.29%
7
40
589
5811
5
14
593
5850
—
—
—
7
14
581
5808
19
72
545
5527
calcium (different salts in combination); oral
A12AA20 [21600872]
9.8e-01
7.2e-01
—
—
—
9.0e-01
6.7e-01
cases:2.68%
controls:1.03%
cases:1.84%
controls:0.90%
—
—
—
—
—
—
cases:2.21%
controls:0.91%
cases:3.90%
controls:2.04%
16
60
580
5791
11
53
587
5811
—
—
—
13
53
575
5769
22
114
542
5485
hydroxyzine; oral, parenteral
N05BB01 [21604590]
—
—
—
—
-1.0e+50
—
9.7e-01
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
cases:2.84%
controls:1.09%
—
—
—
—
0
5
594
5855
—
16
61
548
5538
Scheduled procedure
ZXD10 [2001311387]
7.5e-01
1.1e+00
—
—
—
1.2e+00
9.5e-01
cases:2.68%
controls:1.28%
cases:1.34%
controls:0.46%
—
—
—
—
—
—
cases:1.36%
controls:0.41%
cases:4.79%
controls:1.91%
16
75
580
5776
8
27
590
5837
—
—
—
8
24
580
5798
27
107
537
5492
pivmecillinam; oral
J01CA08 [21602827]
4.9e-01
2.7e-01
—
—
—
2.9e-01
9.5e-01
cases:2.18%
controls:1.35%
cases:1.00%
controls:0.77%
—
—
—
—
—
—
cases:1.19%
controls:0.89%
cases:7.98%
controls:3.25%
13
79
583
5772
6
45
592
5819
—
—
—
7
52
581
5770
45
182
519
5417
temazepam; oral
N05CD07 [21604642]
5.0e-01
4.4e-01
—
—
-1.0e+50
6.5e-01
9.2e-01
cases:1.85%
controls:1.13%
cases:1.51%
controls:0.97%
—
—
—
—
cases:0.00%
controls:0.24%
cases:2.21%
controls:1.17%
cases:8.33%
controls:3.50%
11
66
585
5785
9
57
589
5807
—
—
0
14
594
5846
13
68
575
5754
47
196
517
5403
simvastatin; oral
C10AA01 [21601856]
7.0e-01
5.9e-01
5.4e-01
—
9.8e-01
8.4e-01
5.1e-01
cases:4.03%
controls:2.05%
cases:3.34%
controls:1.88%
cases:1.17%
controls:0.68%
—
—
cases:1.35%
controls:0.51%
cases:4.93%
controls:2.18%
cases:7.45%
controls:4.63%
24
120
572
5731
20
110
578
5754
7
40
591
5824
—
8
30
586
5830
29
127
559
5695
42
259
522
5340
fluconazole; oral, parenteral
J02AC01 [21603080]
7.0e-01
—
—
—
—
3.5e-01
8.2e-01
cases:2.68%
controls:1.35%
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.60%
cases:5.14%
controls:2.32%
16
79
580
5772
—
—
—
—
5
35
583
5787
29
130
535
5469
hydrocortisone
S02BA01 [21605166]
4.0e-01
2.8e-01
—
—
—
6.3e-01
7.8e-01
cases:2.52%
controls:1.71%
cases:0.84%
controls:0.63%
—
—
—
—
—
—
cases:1.53%
controls:0.82%
cases:8.16%
controls:3.93%
15
100
581
5751
5
37
593
5827
—
—
—
9
48
579
5774
46
220
518
5379
metoprolol; oral, parenteral
C07AB02 [21601684]
5.4e-01
3.7e-01
8.7e-01
—
9.9e-01
6.7e-01
7.4e-01
cases:3.19%
controls:1.88%
cases:3.01%
controls:2.10%
cases:1.34%
controls:0.56%
—
—
cases:1.68%
controls:0.63%
cases:4.59%
controls:2.40%
cases:12.94%
controls:6.61%
19
110
577
5741
18
123
580
5741
8
33
590
5831
—
10
37
584
5823
27
140
561
5682
73
370
491
5229
levothyroxine sodium; oral, parenteral
H03AA01 [21602754]
5.0e-01
6.8e-01
—
—
—
6.6e-01
7.3e-01
cases:2.68%
controls:1.64%
cases:3.18%
controls:1.64%
—
—
—
—
—
—
cases:3.40%
controls:1.79%
cases:6.56%
controls:3.29%
16
96
580
5755
19
96
579
5768
—
—
—
20
104
568
5718
37
184
527
5415
hydrocortisone buteprate
D07AB11 [21602115]
3.4e-01
3.2e-01
—
—
—
6.1e-01
7.2e-01
cases:2.68%
controls:1.93%
cases:1.00%
controls:0.73%
—
—
—
—
—
—
cases:1.70%
controls:0.93%
cases:8.87%
controls:4.54%
16
113
580
5738
6
43
592
5821
—
—
—
10
54
578
5768
50
254
514
5345
hydrocortisone aceponate
D07AC16 [21602135]
3.4e-01
3.2e-01
—
—
—
6.1e-01
7.2e-01
cases:2.68%
controls:1.93%
cases:1.00%
controls:0.73%
—
—
—
—
—
—
cases:1.70%
controls:0.93%
cases:8.87%
controls:4.54%
16
113
580
5738
6
43
592
5821
—
—
—
10
54
578
5768
50
254
514
5345
hydrocortisone butyrate
D07AB02 [21602106]
3.4e-01
3.2e-01
—
—
—
6.1e-01
7.2e-01
cases:2.68%
controls:1.93%
cases:1.00%
controls:0.73%
—
—
—
—
—
—
cases:1.70%
controls:0.93%
cases:8.87%
controls:4.54%
16
113
580
5738
6
43
592
5821
—
—
—
10
54
578
5768
50
254
514
5345
hydrocortisone
D07AA02 [21602102]
3.4e-01
3.2e-01
—
—
—
6.1e-01
7.2e-01
cases:2.68%
controls:1.93%
cases:1.00%
controls:0.73%
—
—
—
—
—
—
cases:1.70%
controls:0.93%
cases:8.87%
controls:4.54%
16
113
580
5738
6
43
592
5821
—
—
—
10
54
578
5768
50
254
514
5345
hydrocortisone
A07EA02 [21600654]
3.2e-01
2.1e-01
—
—
—
5.6e-01
7.1e-01
cases:2.68%
controls:1.97%
cases:1.00%
controls:0.82%
—
—
—
—
—
—
cases:1.70%
controls:0.98%
cases:9.40%
controls:4.86%
16
115
580
5736
6
48
592
5816
—
—
—
10
57
578
5765
53
272
511
5327
hydrocortisone
C05AA01 [21601608]
3.2e-01
2.1e-01
—
—
—
5.6e-01
7.1e-01
cases:2.68%
controls:1.97%
cases:1.00%
controls:0.82%
—
—
—
—
—
—
cases:1.70%
controls:0.98%
cases:9.40%
controls:4.86%
16
115
580
5736
6
48
592
5816
—
—
—
10
57
578
5765
53
272
511
5327
omeprazole; oral, parenteral
A02BC01 [21600096]
-6.0e-03
—
—
—
—
6.2e-01
7.0e-01
cases:1.34%
controls:1.35%
—
—
—
—
—
—
—
—
cases:1.87%
controls:1.01%
cases:7.09%
controls:3.64%
8
79
588
5772
—
—
—
—
11
59
577
5763
40
204
524
5395
oxazepam; oral
N05BA04 [21604569]
5.3e-01
7.4e-01
—
—
—
7.3e-01
6.8e-01
cases:1.85%
controls:1.09%
cases:1.67%
controls:0.80%
—
—
—
—
—
—
cases:2.04%
controls:1.00%
cases:5.50%
controls:2.86%
11
64
585
5787
10
47
588
5817
—
—
—
12
58
576
5764
31
160
533
5439
piroxicam; ointment
M02AA07 [21604043]
3.4e-01
3.1e-01
-1.0e+50
—
—
3.1e-01
6.5e-01
cases:2.18%
controls:1.56%
cases:1.51%
controls:1.11%
cases:0.00%
controls:0.12%
—
—
—
—
cases:1.87%
controls:1.37%
cases:10.64%
controls:5.86%
13
91
583
5760
9
65
589
5799
0
7
598
5857
—
—
11
80
577
5742
60
328
504
5271
sulfadiazine and trimethoprim
J01EE02 [21602962]
1.0e-01
1.1e-01
—
—
—
7.9e-01
6.4e-01
cases:1.68%
controls:1.52%
cases:0.84%
controls:0.75%
—
—
—
—
—
—
cases:1.87%
controls:0.86%
cases:7.45%
controls:4.07%
10
89
586
5762
5
44
593
5820
—
—
—
11
50
577
5772
42
228
522
5371
combinations of corticosteroids
D07XB30 [21602188]
-1.3e-02
3.1e-01
—
—
—
5.9e-01
6.1e-01
cases:2.85%
controls:2.89%
cases:1.67%
controls:1.23%
—
—
—
—
—
—
cases:2.55%
controls:1.43%
cases:12.23%
controls:7.04%
17
169
579
5682
10
72
588
5792
—
—
—
15
83
573
5739
69
394
495
5205
combinations of corticosteroids
D07AB30 [21602118]
-1.3e-02
3.1e-01
—
—
—
5.9e-01
6.1e-01
cases:2.85%
controls:2.89%
cases:1.67%
controls:1.23%
—
—
—
—
—
—
cases:2.55%
controls:1.43%
cases:12.23%
controls:7.04%
17
169
579
5682
10
72
588
5792
—
—
—
15
83
573
5739
69
394
495
5205
amoxicillin; oral, parenteral
J01CA04 [21602823]
3.6e-01
1.8e-01
—
—
—
3.5e-01
5.6e-01
cases:7.21%
controls:5.13%
cases:2.51%
controls:2.10%
—
—
—
—
—
—
cases:3.06%
controls:2.18%
cases:16.31%
controls:10.00%
43
300
553
5551
15
123
583
5741
—
—
—
18
127
570
5695
92
560
472
5039
piroxicam; oral, parenteral, rectal
M01AC01 [21603961]
4.1e-01
1.9e-01
-1.0e+50
—
—
1.6e-01
5.1e-01
cases:3.02%
controls:2.02%
cases:1.67%
controls:1.38%
cases:0.00%
controls:0.15%
—
—
—
—
cases:2.04%
controls:1.75%
cases:11.52%
controls:7.23%
18
118
578
5733
10
81
588
5783
0
9
598
5855
—
—
12
102
576
5720
65
405
499
5194
doxycycline; oral, parenteral
J01AA02 [21602800]
2.3e-01
5.2e-01
—
—
—
2.9e-01
4.1e-01
cases:6.88%
controls:5.55%
cases:4.01%
controls:2.42%
—
—
—
—
—
—
cases:4.42%
controls:3.33%
cases:20.92%
controls:14.97%
41
325
555
5526
24
142
574
5722
—
—
—
26
194
562
5628
118
838
446
4761
Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]
3620B [2000403233]
—
—
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.42%
controls:0.00%
—
—
—
—
—
—
8
0
556
5599
polymyxin B
S03AA03 [21605192]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
6
564
5593
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
1.5e-01
—
—
—
—
8.3e-01
2.5e-02
cases:1.17%
controls:1.01%
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.45%
cases:2.30%
controls:2.25%
7
59
589
5792
—
—
—
—
6
26
582
5796
13
126
551
5473
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
596
5844
—
—
—
—
—
—
Vena saphena Magna and / or swarm of nodule and possible local emissions
5611 [2000100813]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.32%
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
0
19
596
5832
0
7
598
5857
—
—
—
—
0
22
564
5577
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
1.7e-01
6.5e-02
—
—
—
-2.6e-01
-4.2e-02
cases:4.03%
controls:3.44%
cases:1.67%
controls:1.57%
—
—
—
—
—
—
cases:1.70%
controls:2.20%
cases:8.51%
controls:8.84%
24
201
572
5650
10
92
588
5772
—
—
—
10
128
578
5694
48
495
516
5104
Dysphagia
R13 [45573013]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
0
7
596
5844
—
—
—
—
—
0
12
564
5587
Acute conjunctivitis, unspecified
H10.3 [45566958]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
0
5
596
5846
—
—
—
—
—
0
7
564
5592
Other investigative procedure of eye
XCW99 [2001301491]
—
—
—
—
—
—
9.1e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.36%
—
—
—
—
—
—
5
20
559
5579
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
0
17
596
5834
—
—
—
—
—
—
Chronic tonsillitis
J35.0 [45548113]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
0
5
564
5594
Cataract, Infantile, juvenile and presenile cataract[CATARACTA PRAESENILIS]
3660C [2000403304]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
596
5843
—
—
—
—
—
—
Local excisions and / or perforations of relapsing varicose veins
5612 [2000100814]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.32%
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:0.00%
controls:0.12%
—
—
0
19
596
5832
0
6
598
5858
—
—
—
0
7
588
5815
—
oxybutynin; oral, transdermal
G04BD04 [21602637]
—
-1.0e+50
—
—
—
—
1.0e+00
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
cases:2.48%
controls:0.93%
—
0
5
598
5859
—
—
—
—
14
52
550
5547
Varicose veins of lower extremities without ulcer or inflammation
I83.9 [45552859]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
0
14
596
5837
—
—
—
—
0
5
588
5817
—
etoricoxib; oral
M01AH05 [21603996]
3.3e-02
5.4e-01
—
—
—
—
-8.1e-01
cases:1.34%
controls:1.30%
cases:1.17%
controls:0.68%
—
—
—
—
—
—
—
—
cases:0.89%
controls:1.96%
8
76
588
5775
7
40
591
5824
—
—
—
—
5
110
559
5489
Glomerular disorders in diabetes mellitus and Type 2 diabetes mellitus, with renal complications
N08.3*E11.2 [2000504105]
1.0e+50
—
—
—
—
—
1.0e+50
cases:0.84%
controls:0.00%
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.00%
5
0
591
5851
—
—
—
—
—
7
0
557
5599
Support of social functional capacity
SPAT1234 [2001700335]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
0
5
564
5594
Intravenous general anesthesia
WX404 [2001310807]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.25%
—
—
—
—
—
—
5
14
559
5585
influenza, inactivated, split virus or surface antigen
J07BB02 [21601335]
-1.8e-01
-2.0e-02
-1.0e+50
—
—
—
1.5e-02
cases:1.34%
controls:1.61%
cases:1.17%
controls:1.19%
cases:0.00%
controls:0.12%
—
—
—
—
—
—
cases:2.48%
controls:2.45%
8
94
588
5757
7
70
591
5794
0
7
598
5857
—
—
—
14
137
550
5462
Uncompl labour/delivery livebirth
W90 [2002001277]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
0
7
564
5592
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
0
5
564
5594
Gynaecological examination
SPAT1192 [2001700293]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
596
5842
—
—
—
—
—
—
diclofenac
D11AX18 [21602355]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
0
39
564
5560
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
H90.4 [45572067]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
0
5
596
5846
—
—
—
—
—
0
8
564
5591
Surveillance of (intrauterine) contraceptive device
Z30.5 [45547300]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
596
5844
—
—
—
—
—
—
triamterene; oral
C03DB02 [21601540]
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
0
6
594
5854
—
—
Tremor, unspecified
R25.1 [45539327]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
0
5
564
5594
Fitting and adjustment of hearing aid
Z46.1 [45595518]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
0
5
598
5859
—
—
—
—
0
11
564
5588
Hyperplasia of prostate[HYPERPLASIA PROSTATAE]
6000A [2000404725]
—
—
—
—
—
—
1.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.77%
controls:0.63%
—
—
—
—
—
—
10
35
554
5564
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
596
5845
—
—
—
—
—
—
Migraine, unspecified
G43.9 [45595943]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
0
5
596
5846
—
—
—
—
—
0
6
564
5593
desogestrel
G03AC09 [21602505]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
0
8
598
5856
—
—
—
—
—
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
9694A [2000408566]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
0
5
564
5594
formoterol and beclometasone
R03AK08 [43534839]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
596
5846
—
—
—
—
—
—
Seronegative rheumatoid arthritis
M06.0 [45577103]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
0
7
596
5844
—
—
—
—
0
5
588
5817
—
Presence of intraocular lens
Z96.1 [45585885]
—
—
—
—
—
—
1.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.60%
controls:0.57%
—
—
—
—
—
—
9
32
555
5567
Other specified arthrosis
M19.8 [45548327]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
0
7
564
5592
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
—
1.4e+00
—
1.0e+50
1.0e+50
—
—
—
—
cases:0.84%
controls:0.20%
—
—
cases:1.00%
controls:0.00%
cases:1.01%
controls:0.00%
—
—
—
—
—
5
12
593
5852
—
6
0
592
5864
6
0
588
5860
—
—
Haemorrhage of anus and rectum
K62.5 [45596339]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
0
9
564
5590
Genital prolapse, Uterovaginal prolapse, incomplete
6182A [2000404840]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
0
5
596
5846
—
—
—
—
—
0
6
564
5593
trazodone; oral
N06AX05 [21604734]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
0
5
588
5817
—
Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]
5742A [2000404528]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
0
7
598
5857
—
—
—
—
—
Adenocarcinoma, NOS, of sigmoid colon
8140/3-C18.7 [44504380]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
6
564
5593
Prolactin [Units/volume] in Serum or Plasma
15081-3 [3021387]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
596
5843
—
—
—
—
—
—
fludrocortisone and antiinfectives
S02CA07 [21605179]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
6
564
5593
Inflammatory disorders of breast
N61 [45543886]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
6
564
5593
propranolol; oral, parenteral
C07AA05 [21601670]
—
—
—
—
-1.0e+50
—
5.7e-01
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
cases:2.66%
controls:1.52%
—
—
—
—
0
9
594
5851
—
15
85
549
5514
Late effects of musculoskeletal and connective tissue injuries, Late effect of fracture of lower extremities
9054A [2000407944]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
596
5842
—
—
—
—
—
—
Functional disorders of intestines, Constipation
56400 [2000303177]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
596
5846
—
—
—
—
—
—
Ultrasound measurement of residual urine
KC1EE [2001305918]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
596
5845
—
—
—
—
—
—
Phlebitis and thrombophlebitis, Of deep vessels of lower extremities
4511A [2000403822]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.29%
—
—
—
—
—
—
7
16
557
5583
Hearing complaint
H02 [2002000476]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
0
5
588
5817
—
Timothy IgE Ab [Units/volume] in Serum
6265-3 [3003888]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
0
9
564
5590
Orthodontic treatment/control appointment, short
SJX10 [2001310452]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
596
5846
—
—
—
—
—
—
Cholesterol non HDL [Moles/volume] in Serum or Plasma
70204-3 [42868678]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
0
7
564
5592
indometacin; oral, parenteral, rectal
M01AB01 [21603941]
—
—
-1.0e+50
—
—
—
-3.2e-01
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:1.42%
controls:1.95%
—
—
0
6
598
5858
—
—
—
8
109
556
5490
Low back pain
M54.5 [45553207]
—
—
—
—
—
-1.0e+50
2.2e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.36%
cases:1.06%
controls:0.86%
—
—
—
—
—
0
21
588
5801
6
48
558
5551
Type 1 diabetes mellitus, Without complications
E10.9 [45581351]
—
—
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
—
—
—
—
—
cases:12.37%
controls:0.00%
cases:6.57%
controls:0.00%
cases:9.01%
controls:0.00%
cases:9.04%
controls:0.00%
—
—
—
74
0
524
5864
39
0
555
5860
53
0
535
5822
51
0
513
5599
sumatriptan; nasal, oral, parenteral, rectal
N02CC01 [21604376]
—
—
-1.0e+50
—
—
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
0
6
598
5858
—
—
0
18
588
5804
—
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
—
—
—
1.0e+50
—
1.0e+50
1.0e+50
—
—
—
—
—
—
cases:1.84%
controls:0.00%
—
—
cases:1.53%
controls:0.00%
cases:1.95%
controls:0.00%
—
—
—
11
0
587
5864
—
9
0
579
5822
11
0
553
5599
natamycin; oral
A07AA03 [21600605]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.14%
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
0
8
596
5843
0
6
598
5858
—
—
—
0
5
588
5817
—
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
2500A [2000402294]
—
—
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
—
—
—
—
—
cases:42.47%
controls:0.00%
cases:4.21%
controls:0.00%
cases:11.90%
controls:0.00%
cases:23.40%
controls:0.00%
—
—
—
254
0
344
5864
25
0
569
5860
70
0
518
5822
132
0
432
5599
oxycodone; oral, parenteral
N02AA05 [21604260]
—
—
—
—
—
—
1.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.43%
—
—
—
—
—
—
7
24
557
5575
Nursing episode
950 [44777714]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
596
5846
—
—
—
—
—
—
Rectocele
N81.6 [45543893]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.09%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
0
5
596
5846
0
5
598
5859
—
—
—
—
—
selegiline; oral
N04BD01 [21604483]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
596
5846
—
—
—
—
—
—
salmeterol; inhalant
R03AC12 [21603266]
—
—
—
—
—
—
9.9e-02
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.96%
—
—
—
—
—
—
6
54
558
5545
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
5.0e-01
1.0e+00
—
—
—
—
-1.7e-01
cases:0.84%
controls:0.51%
cases:0.84%
controls:0.31%
—
—
—
—
—
—
—
—
cases:1.24%
controls:1.46%
5
30
591
5821
5
18
593
5846
—
—
—
—
7
82
557
5517
Counselling and guidance related to physical exercise
SPAT1305 [2001700406]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
596
5844
—
—
—
—
—
—
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
1.5e-01
—
—
—
—
8.3e-01
2.5e-02
cases:1.17%
controls:1.01%
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.45%
cases:2.30%
controls:2.25%
7
59
589
5792
—
—
—
—
6
26
582
5796
13
126
551
5473
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.15%
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
0
9
596
5842
0
7
598
5857
—
—
—
—
—
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
2.3e-01
2.6e-01
—
—
—
5.0e-01
3.5e-01
cases:1.68%
controls:1.33%
cases:0.84%
controls:0.65%
—
—
—
—
—
—
cases:1.02%
controls:0.62%
cases:1.77%
controls:1.25%
10
78
586
5773
5
38
593
5826
—
—
—
6
36
582
5786
10
70
554
5529
Migraine with aura [classical migraine]
G43.1 [45562086]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
0
6
596
5845
—
—
—
—
0
6
588
5816
—
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
1.0e+50
1.0e+50
—
—
—
1.0e+50
1.0e+50
cases:1.85%
controls:0.00%
cases:2.01%
controls:0.00%
—
—
—
—
—
—
cases:2.38%
controls:0.00%
cases:7.98%
controls:0.00%
11
0
585
5851
12
0
586
5864
—
—
—
14
0
574
5822
45
0
519
5599
Influenza virus B Ag [Presence] in Specimen
31864-2 [3003740]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
596
5845
—
—
—
—
—
—
Transurethral resection of prostate
KED22 [2001306138]
—
—
—
—
—
—
8.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.38%
—
—
—
—
—
—
5
21
559
5578
antibiotics in combination with other drugs
S01AA20 [21603571]
1.9e-01
—
—
—
—
-5.9e-02
6.0e-01
cases:1.85%
controls:1.54%
—
—
—
—
—
—
—
—
cases:1.02%
controls:1.08%
cases:6.91%
controls:3.93%
11
90
585
5761
—
—
—
—
6
63
582
5759
39
220
525
5379
long-acting sulfonamides - combinations
J01ED20 [21602959]
4.8e-01
—
—
—
—
4.4e-01
4.9e-01
cases:1.68%
controls:1.04%
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.55%
cases:4.26%
controls:2.66%
10
61
586
5790
—
—
—
—
5
32
583
5790
24
149
540
5450
Osmolality of Urine
2695-5 [3026782]
—
—
—
—
—
—
1.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.36%
—
—
—
—
—
—
6
20
558
5579
Oral health check
SAB03 [2001310281]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
0
7
598
5857
—
—
—
—
—
tioconazole; vaginal
G01AF08 [21602398]
—
-1.0e+50
—
—
—
—
1.0e+00
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
cases:1.06%
controls:0.39%
—
0
12
598
5852
—
—
—
—
6
22
558
5577
Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia
6266A [2000404934]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
596
5844
—
—
—
—
—
—
Bradycardia, unspecified
R00.1 [45539313]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
596
5846
—
—
—
—
—
—
Polyuria
R35 [45539331]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
596
5845
—
—
—
—
—
—
Cholelithiasis, Calculus of gallbladder with other cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE CHR,SINE OBS]
5741A [2000404526]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
596
5846
—
—
—
—
—
—
anastrozole; oral
L02BG03 [21603841]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
0
5
564
5594
Sensorineural hearing loss, bilateral
H90.3 [45576850]
—
—
—
—
—
—
-1.0e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.98%
—
—
—
—
—
—
5
55
559
5544
beclometasone; nasal
R01AD01 [21605043]
—
—
—
—
—
—
1.2e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.77%
controls:1.57%
—
—
—
—
—
—
10
88
554
5511
Coxarthrosis, unspecified
M16.9 [45591742]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
0
8
564
5591
Cholecystectomy and choledocotomy
6664 [2000101067]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
0
8
564
5591
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
—
1.8e+00
—
—
—
—
6.1e-01
—
—
cases:0.84%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.68%
—
5
8
593
5856
—
—
—
—
7
38
557
5561
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.27%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
0
16
596
5835
0
5
598
5859
—
—
—
—
—
lidocaine, combinations
N01BB52 [21604241]
—
—
—
—
—
-1.0e+50
3.0e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.19%
cases:0.89%
controls:0.66%
—
—
—
—
—
0
11
588
5811
5
37
559
5562
methylphenidate; oral
N06BA04 [21604757]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.14%
cases:0.00%
controls:0.10%
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
0
8
596
5843
0
6
598
5858
—
—
—
0
6
588
5816
—
fluocinolone acetonide and antiinfectives
S02CA05 [21605177]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
0
6
596
5845
—
—
—
—
—
0
19
564
5580
Asthma
R96 [2002000961]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
6
564
5593

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
169
4601
0.16
107.79
39.2
25.5
7.17
6.88
e9/l
0.77
159
4462
169
4600
0.16
107.70
39.0
25.5
4.38
4.37
e12/l
0.10
159
4464
169
4599
0.16
107.61
39.3
25.5
255.04
238.91
e9/l
2.03
161
4472
156
4358
0.17
96.24
15.6
10.6
24.54
24.47
u/l
0.02
147
4182
151
4313
0.16
96.04
28.9
17.7
24.04
28.76
mg/l
1.41
122
3614
158
4337
0.17
93.26
24.9
15.3
—
—
—
0
0
111
3849
0.15
88.61
5.3
4.2
8.22
5.60
mmol/l
9.22
94
3405
168
4351
0.18
87.84
35.9
20.8
4.07
4.00
mmol/l
2.24
163
4225
158
3873
0.23
62.56
7.5
4.8
2.20
2.66
mmol/l
11.57
150
3464
151
3771
0.23
60.63
7.3
4.6
2.09
2.00
mu/l
0.13
143
3381
157
3764
0.24
57.14
6.8
4.3
4.08
4.52
mmol/l
8.18
150
3387
121
3380
0.22
56.00
10.8
7.2
95.86
85.04
u/l
0.74
115
3148
157
3727
0.25
55.21
6.8
4.2
1.48
1.46
mmol/l
0.22
149
3329
104
3093
0.22
51.06
6.7
4.8
—
4.90
—
0
5
148
3539
0.26
50.32
5.4
3.6
1.13
1.15
mmol/l
0.16
139
3129
161
3640
0.27
48.95
13.8
4.2
54.59
36.55
mmol/mol
40.73
152
3278
112
2888
0.27
38.80
5.2
4.1
—
0.44
—
0
9
131
3080
0.29
38.15
5.8
3.7
14.90
14.95
pmol/l
0.09
123
2745
86
2374
0.27
31.12
21.5
18.4
1.30
1.39
inr
0.80
78
2031
100
2514
0.29
30.25
12.9
8.7
4.37
4.23
e9/l
0.23
86
2155
87
2359
0.28
30.22
7.3
5.9
11.99
13.72
umol/l
0.58
81
2227
34
1670
0.16
30.13
2.8
5.9
3.39
3.73
ug/l
0.08
28
1460
65
2046
0.25
28.88
2.3
2.2
90.47
93.14
pmol/l
0.14
35
1097
89
2337
0.29
28.70
5.9
4.3
0.22
0.58
estimate
0.26
23
514
89
2334
0.29
28.60
5.9
4.2
0.00
3.16
estimate
0.50
24
516
88
2289
0.29
27.54
5.9
4.2
0.00
0.00
estimate
0.50
26
498
104
2428
0.32
25.93
19.4
6.8
1.20
1.21
mmol/l
1.04
95
2053
64
1920
0.26
25.33
6.5
4.0
96.96
44.74
ng/l
0.65
55
1416
98
2277
0.33
23.47
10.7
6.1
0.20
0.20
e9/l
0.11
84
1958
96
2237
0.34
22.99
10.3
5.9
1.72
1.76
e9/l
0.18
85
1946
51
1650
0.25
22.37
2.6
2.3
—
—
—
0
0
95
2196
0.34
22.13
10.3
5.8
0.61
0.60
e9/l
0.19
83
1863
96
2207
0.34
22.11
10.2
5.8
0.04
0.04
e9/l
0.62
83
1875
83
2034
0.33
21.65
3.6
2.8
—
—
estimate
—
0
0
36
1415
0.21
21.55
1.9
1.7
23.71
19.58
nmol/l
0.63
28
1191
70
1853
0.31
21.11
5.3
3.8
6.43
6.34
ph
0.30
50
1013
74
1857
0.32
19.81
6.4
4.2
77.71
144.62
e6/l
0.79
56
1371
24
7
35.46
19.00
1.4
1.0
100.43
—
iu/ml
—
7
0
82
1900
0.35
18.27
18.8
11.4
0.00
0.00
e9/l
1.03
62
1521
71
1754
0.34
18.03
6.0
4.3
0.00
0.05
estimate
2.54
22
415
17
967
0.15
16.96
1.8
3.5
0.77
0.86
ug/l
0.31
12
661
70
1697
0.34
16.86
6.2
3.6
30.14
75.99
e6/l
2.04
56
1328
64
1616
0.33
16.74
4.7
3.7
—
—
—
0
0
92
1912
0.40
15.43
3.8
2.4
71.07
77.36
nmol/l
1.96
85
1687
32
1121
0.25
15.10
1.4
1.4
—
—
—
0
0
59
1477
0.34
14.84
3.4
3.7
—
0.88
—
0
8
65
1547
0.36
14.66
6.7
4.3
—
—
—
0
0
58
1450
0.34
14.49
6.7
3.6
0.54
0.48
e6/l
0.08
44
1100
46
1283
0.31
14.28
9.5
6.4
—
—
—
0
0
54
1386
0.34
14.19
2.6
2.3
2.95
2.88
mg/l
0.09
48
1160
66
1528
0.37
13.88
3.1
2.6
—
—
—
0
0
64
1500
0.37
13.81
9.7
6.0
—
—
—
0
0
22
15
15.11
13.65
3.0
3.1
9.40
66.50
ug/min
—
10
6
57
1390
0.36
13.33
5.5
3.6
—
0.00
estimate
—
0
10
31
1021
0.27
12.93
7.9
4.2
387.03
333.52
ng/l
0.08
26
871
47
1225
0.34
12.53
5.1
2.7
—
—
—
0
0
48
1213
0.35
11.92
5.6
3.8
0.00
0.09
estimate
0.74
22
388
68
1462
0.41
11.72
13.1
3.8
7.40
7.40
ph
0.07
55
1038
59
1333
0.39
11.38
6.4
4.3
0.00
0.01
estimate
0.69
24
444
138
763
2.01
11.19
6.1
2.0
64.03
65.34
mg/l
0.02
112
438
33
969
0.31
10.98
1.8
1.7
492.11
7566651.53
pmol/l
0.50
27
793
41
1069
0.34
10.75
5.9
4.4
1.02
1.02
kg/l
0.15
28
706
50
1163
0.38
10.16
8.3
4.3
82.60
82.91
%
0.03
50
1143
138
788
1.94
10.13
7.0
2.3
12.75
35.83
mg/mmol
0.44
107
443
30
861
0.32
9.44
3.7
3.5
3.57
2.11
e6/l
0.51
11
471
38
923
0.38
8.37
1.7
2.1
1.40
1.49
mg/l
0.09
32
723
19
577
0.31
6.59
1.4
1.4
—
—
—
0
0
135
870
1.69
6.44
6.0
2.6
7.30
7.64
mmol/l
0.46
125
733
23
613
0.35
6.13
1.3
1.3
12.97
26.22
iu/ml
—
9
187
21
568
0.35
5.77
1.5
1.3
1.40
12.32
u/ml
—
8
213
45
859
0.49
5.22
10.0
4.5
—
—
—
0
0
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
85
1324
0.59
4.93
3.2
1.8
1.08
1.19
mmol/l
1.16
80
1124
17
470
0.35
4.90
4.6
3.2
848.51
320.63
ng/l
1.51
17
434
13
406
0.31
4.77
1.2
1.3
—
—
—
0
0
17
456
0.36
4.60
2.8
2.9
3.43
5.24
e9/l
1.34
17
379
0
102
0.00
4.06
0.0
1.1
—
—
—
0
0
13
371
0.34
4.02
1.4
1.5
—
—
—
0
0
33
623
0.51
3.69
2.5
1.9
—
—
—
0
0
8
250
0.31
3.64
2.0
2.6
—
—
—
0
0
26
523
0.48
3.51
1.0
1.3
—
—
—
0
0
45
760
0.56
3.49
3.2
2.6
29.58
30.01
s
0.30
45
739
15
360
0.40
3.21
1.8
1.6
—
—
—
0
0
19
408
0.45
3.09
2.6
2.3
0.21
0.65
e6/l
2.15
19
389
7
210
0.33
2.97
2.0
2.8
—
—
—
0
0
6
196
0.30
2.97
2.0
1.9
—
—
—
0
0
27
500
0.52
2.87
1.6
1.4
1112.00
454.81
titre
—
5
108
6
9
6.71
2.87
5.0
2.3
—
—
—
0
0
24
461
0.50
2.86
15.4
7.1
1.28
1.40
mmol/l
0.41
24
448
34
584
0.56
2.81
11.1
6.3
7.41
7.42
ph
0.14
21
338
34
582
0.56
2.78
10.8
6.3
-0.22
1.21
mmol/l
0.87
26
469
5
6
8.38
2.75
4.0
2.0
0.66
0.59
mmol/l
—
5
6
12
290
0.40
2.65
1.8
1.7
—
—
—
0
0
5
7
7.19
2.55
2.6
1.1
—
—
—
0
0
27
474
0.55
2.43
1.7
1.4
—
—
—
0
0
17
341
0.49
2.34
1.5
1.5
—
—
—
0
0
43
658
0.63
2.28
2.5
1.8
—
—
—
0
0
0
61
0.00
2.24
0.0
1.4
—
—
—
0
0
15
302
0.49
2.11
14.5
8.5
22.67
24.61
mmol/l
0.99
15
290
0
57
0.00
2.06
0.0
1.2
—
—
—
0
0
7
178
0.39
2.05
2.9
2.8
19.14
59.17
u/ml
—
7
172
17
312
0.53
1.83
12.2
8.9
94.49
93.72
%
0.34
17
312
19
336
0.55
1.80
11.2
4.2
0.00
0.12
%
—
8
106
5
135
0.37
1.77
1.0
1.7
—
—
—
0
0
5
138
0.36
1.76
1.0
1.2
—
—
—
0
0
32
489
0.64
1.72
2.8
1.7
—
—
—
0
0
0
47
0.00
1.71
0.0
1.3
—
—
—
0
0
22
367
0.59
1.70
7.3
4.4
—
—
—
0
0
29
449
0.63
1.66
12.0
6.9
118.10
119.92
g/l
0.18
29
437
6
148
0.40
1.65
1.0
1.2
—
—
—
0
0
58
783
0.72
1.65
1.7
1.5
2.02
2.41
g/l
0.98
25
458
13
250
0.51
1.64
2.2
1.5
—
—
—
0
0
5
131
0.38
1.64
1.2
1.3
—
2.17
—
0
13
20
335
0.58
1.59
1.5
2.6
—
—
—
0
0
11
221
0.49
1.58
1.7
1.9
0.78
2.71
ug/l
0.78
11
187
6
141
0.42
1.53
7.5
10.7
—
—
—
0
0
0
42
0.00
1.53
0.0
1.3
—
—
—
0
0
11
217
0.50
1.51
1.3
1.3
—
—
—
0
0
21
341
0.60
1.49
10.2
3.9
0.55
0.62
%
0.07
11
119
19
314
0.59
1.45
5.7
3.5
—
—
—
0
0
5
16
3.14
1.44
2.2
1.4
6.72
8.11
mmol/l
—
5
16
39
549
0.69
1.43
2.2
1.7
—
—
—
0
0
0
38
0.00
1.34
0.0
1.8
—
—
—
0
0
23
355
0.64
1.34
9.5
4.1
0.75
0.89
%
0.17
12
126
0
41
0.00
1.31
0.0
2.7
—
—
—
0
0
18
293
0.60
1.31
9.8
3.1
122.44
124.96
g/l
0.15
18
284
26
388
0.66
1.30
2.8
1.6
—
—
—
0
0
22
339
0.64
1.28
9.7
4.4
0.00
0.11
%
—
9
100
0
33
0.00
1.16
0.0
1.4
—
67.74
—
0
27
0
34
0.00
1.16
0.0
1.4
—
19.76
—
0
25
10
184
0.54
1.15
2.5
2.1
125.80
660.11
ug/l
—
10
172
0
36
0.00
1.14
0.0
1.3
—
25917.91
—
0
22
5
113
0.44
1.13
1.6
1.5
309.80
300.36
mu/l
—
5
104
7
137
0.51
1.10
1.0
1.1
—
—
—
0
0
10
181
0.55
1.10
1.6
1.2
—
—
—
0
0
16
248
0.64
0.99
1.7
2.0
1.17
1.57
g/l
0.65
16
221
13
211
0.61
0.98
12.7
3.5
24.77
25.08
mmol/l
0.08
13
202
0
29
0.00
0.98
0.0
1.0
—
283.93
—
0
15
0
31
0.00
0.96
0.0
2.6
—
35.32
—
0
22
6
27
2.23
0.93
1.5
1.4
—
—
—
0
0
17
249
0.67
0.83
14.6
9.0
15.95
15.64
%
0.16
17
237
25
341
0.72
0.83
14.0
4.4
196.08
83.38
ng/l
2.40
25
287
42
530
0.78
0.82
11.8
4.5
7.34
7.38
ph
1.95
30
327
25
339
0.73
0.81
7.3
6.0
7.41
7.42
ph
0.50
19
294
11
176
0.62
0.81
9.4
3.8
0.85
0.93
%
0.29
11
161
35
450
0.77
0.79
10.1
4.5
5.24
4.67
kpa
0.57
35
444
0
26
0.00
0.78
0.0
1.3
—
1.18
—
0
21
0
27
0.00
0.77
0.0
3.5
—
0.67
—
0
27
6
107
0.56
0.73
1.0
1.9
545.83
459.65
mg/l
—
6
101
13
194
0.66
0.72
7.2
7.3
23.94
24.94
mmol/l
1.33
13
179
15
216
0.69
0.70
1.4
1.3
—
44.49
—
0
17
11
168
0.65
0.68
2.6
3.8
21.09
20.89
s
0.08
11
161
8
128
0.62
0.64
8.6
4.2
2.09
1.36
mmol/l
—
8
113
18
245
0.73
0.62
5.3
6.3
—
—
—
0
0
0
20
0.00
0.60
0.0
1.3
—
249.21
—
0
8
0
20
0.00
0.60
0.0
1.1
—
57.72
—
0
20
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.2
—
169.76
—
0
23
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
52
612
0.84
0.57
20.6
6.0
1.19
1.06
mmol/l
1.82
52
557
14
191
0.73
0.51
1.4
1.3
240.51
103.51
u/ml
—
7
68
45
526
0.85
0.48
10.9
4.5
5.95
5.84
kpa
0.35
45
515
8
120
0.66
0.46
1.3
1.2
—
—
—
0
0
7
51
1.38
0.44
2.3
1.5
18.86
27.40
ng/l
—
7
51
6
91
0.66
0.42
1.0
1.9
4.40
3.47
mmol/l
—
6
85
14
105
1.34
0.41
7.5
4.7
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
37.39
—
0
10
0
16
0.00
0.41
0.0
6.8
—
103.67
—
0
9
0
16
0.00
0.41
0.0
3.9
—
31.58
—
0
11
0
16
0.00
0.41
0.0
1.0
—
135.81
—
0
16
0
17
0.00
0.40
0.0
1.1
—
158.04
—
0
17
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
15
193
0.77
0.39
7.2
3.7
1.47
1.56
%
0.23
15
177
39
447
0.86
0.35
13.3
8.7
—
—
—
0
0
6
88
0.68
0.33
8.7
4.6
102.67
104.95
mmol/l
—
6
78
6
88
0.68
0.33
8.7
4.6
14.17
11.28
mmol/l
—
6
78
6
82
0.73
0.24
5.7
2.3
1.55
1.52
mmol/l
—
6
82
80
855
0.93
0.23
2.4
1.3
3.80
1.37
u/ml
0.47
24
207
0
11
0.00
0.21
0.0
1.3
—
75.00
—
0
11
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
2.8
—
35.91
—
0
11
0
11
0.00
0.21
0.0
5.6
—
10.09
—
0
11
0
10
0.00
0.21
0.0
1.1
—
1.79
—
0
5
0
10
0.00
0.21
0.0
1.5
—
162.70
—
0
10
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
0.00
—
0
12
0
12
0.00
0.21
0.0
1.4
—
28.92
—
0
12
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
3.8
—
1.43
—
0
12
5
43
1.16
0.21
10.4
3.3
9.84
11.00
%
—
5
43
0
13
0.00
0.21
0.0
1.0
—
1420.77
—
0
13
0
14
0.00
0.20
0.0
2.4
—
3.07
—
0
14
0
14
0.00
0.20
0.0
2.4
—
28.43
—
0
14
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
34
309
1.11
0.18
1.3
1.2
—
—
—
0
0
8
71
1.13
0.16
1.7
1.3
—
—
—
0
0
8
72
1.11
0.16
3.4
3.3
4.84
4.34
e9/l
—
8
72
38
408
0.93
0.14
23.4
7.2
14.52
10.43
mmol/l
1.98
38
392
10
84
1.19
0.14
8.6
3.2
19.92
9.75
pmol/l
—
10
84
9
107
0.84
0.13
8.0
2.3
70.14
60.09
%
—
9
107
13
146
0.89
0.10
21.3
10.8
2.24
1.47
mg/l
1.06
13
130
7
66
1.06
0.08
2.1
1.3
—
—
—
0
0
6
74
0.81
0.07
2.0
1.6
—
—
—
0
0
7
84
0.83
0.07
3.3
3.6
44533.57
560.31
u/ml
—
7
78
13
123
1.06
0.01
2.1
1.7
—
—
—
0
0
10
95
1.05
0.00
3.1
3.0
67.30
60.66
%
—
10
95
0
5
0.00
-0.00
0.0
10.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
76.00
—
0
7
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
76.00
—
0
8
0
6
0.00
-0.00
0.0
2.7
—
3343.83
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
0.05
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
73.98
—
0
5
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
5.0
—
14.39
—
0
9
0
5
0.00
-0.00
0.0
9.4
—
0.61
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
8
86
0.93
-0.00
1.6
1.3
29.83
29.18
g/l
—
8
80
0
8
0.00
-0.00
0.0
1.3
—
2.61
—
0
8
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
0.51
—
0
7
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.7
—
24.70
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
0.02
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
67
0.89
-0.00
7.3
2.3
34.50
32.36
pg
—
6
67
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.0
—
824.50
—
0
6
8
88
0.91
-0.00
1.6
1.3
—
85.56
—
0
9
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
59
0.85
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint T1D_WIDE2 and mortality.

Females

Parameter HR [95% CI] p-value
T1D_WIDE2 6.681 [5.35, 8.35] < 0.001
Birth year 0.996 [0.99, 1.0] 0.368

During the follow-up period (1.1.1998 — 31.12.2019), 331 out of 651 females with T1D_WIDE2 died.

Males

Parameter HR [95% CI] p-value
T1D_WIDE2 7.376 [6.0, 9.07] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 592 out of 1001 males with T1D_WIDE2 died.

Mortality risk

Mortality risk for people of age

years, who have T1D_WIDE2.

N-year risk Females Males
1 0.619% 1.217%
5 4.152% 8.264%
10 9.596% 19.66%
15 17.983% 34.211%
20 28.735% 51.143%

Relationships between endpoints

↥

Index endpoint: T1D_WIDE2 – Type 1 diabetes, wide definition, subgroup 2

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data